var title_f22_19_22832="Retromembranous bleed 2";
var content_f22_19_22832=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F51286&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F51286&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Retromembranous bleed 2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 233px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Arrows point to a retromembranous bleed.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charles Lockwood, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22832=[""].join("\n");
var outline_f22_19_22832=null;
var title_f22_19_22833="Position of the RF catheter";
var content_f22_19_22833=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F52786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F52786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The \"Stretta\" procedure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 282px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Radiofrequency energy catheter positioned within esophageal lumen at gastroesophageal junction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of George Triadafilopoulos, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22833=[""].join("\n");
var outline_f22_19_22833=null;
var title_f22_19_22834="Mini-case session #5: Potassium disorders";
var content_f22_19_22834=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mini-case session #5: Potassium disorders",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/19/22834/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/19/22834/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/19/22834/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/19/22834/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/19/22834/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/19/22834/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/19/22834/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 28, 1995.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     CASE 1",
"    </span>",
"    &nbsp;&mdash;&nbsp;An 82 year-old man is in the hospital awaiting surgery for an enlarged prostate gland. He has a history of type 2 diabetes mellitus for 15 years and mild hypertension that has been treated with a thiazide diuretic and a nonselective &szlig;-adrenergic blocker. Physical examination reveals a euvolemic patient with a blood pressure of",
"    <span class=\"nowrap\">",
"     140/95.",
"    </span>",
"    His laboratory tests 1 year ago and on admission include:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;BUN &nbsp;= &nbsp;36",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    &nbsp;&mdash;&gt; &nbsp;48",
"    <span class=\"nowrap\">",
"     mg/dL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma creatinine &nbsp;= &nbsp;2.4",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    &nbsp;&mdash;&gt; &nbsp;2.9",
"    <span class=\"nowrap\">",
"     mg/dL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma potassium &nbsp;= &nbsp;5.1",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    &nbsp;&mdash;&gt; &nbsp;5.6",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma sodium &nbsp;= &nbsp;138",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    &nbsp;&mdash;&gt; &nbsp;139",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"   </p>",
"   <p>",
"    Multiple repeat measurements demonstrate that, on a regular diet, the plasma potassium concentration remains stable.",
"   </p>",
"   <p>",
"    &nbsp;A. &nbsp;What factors are contributing to the hyperkalemia in this setting? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/5/33882?source=see_link\">",
"     \"Causes and evaluation of hyperkalemia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9930?source=see_link\">",
"     \"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    &nbsp;B. &nbsp;Would measurement of urinary potassium excretion be helpful in the differential diagnosis?",
"   </p>",
"   <p>",
"    &nbsp;C. &nbsp;If, in a normal subject, potassium intake were increased from 60 to 120",
"    <span class=\"nowrap\">",
"     meq/day,",
"    </span>",
"    what will happen in the steady state to urinary potassium excretion and the plasma potassium concentration? Why doesn't the plasma potassium concentration return to the previous baseline?",
"   </p>",
"   <p>",
"    &nbsp;D. &nbsp;Would an angiotensin converting enzyme inhibitor be useful as an antihypertensive agent? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9930?source=see_link\">",
"     \"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CASE 2",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 43 year-old woman has had mild hypertension for 1 to 2 years that has not been treated. She now complains of mild weakness and comes to see her physician. There is a positive family history for hypertension. Physical examination demonstrates a blood pressure of",
"    <span class=\"nowrap\">",
"     150/95",
"    </span>",
"    without orthostatic change, benign fundoscopic examination, no edema, and mild diffuse muscle weakness. Laboratory data include:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;Plasma sodium &nbsp;= &nbsp;137",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma potassium &nbsp;= &nbsp;2.6",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma chloride &nbsp;= &nbsp;95",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma bicarbonate &nbsp;= &nbsp;31",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Arterial pH &nbsp;= &nbsp;7.49",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;Urine sodium &nbsp;= &nbsp;32",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Urine potassium &nbsp;= &nbsp;49",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"   </p>",
"   <p>",
"    &nbsp;A. &nbsp;What is the primary differential diagnosis of hypertension complicated by hypokalemia? Think of physiologic mechanisms in hypertensive patients that could increase urinary potassium excretion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/13/5338?source=see_link\">",
"     \"Approach to the patient with hypertension and hypokalemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    &nbsp;B. &nbsp;How would the plasma renin activity be helpful in distinguishing between these possibilities?",
"   </p>",
"   <p>",
"    &nbsp;C. &nbsp;Does the lack of edema exclude primary mineralocorticoid excess? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37911?source=see_link\">",
"     \"Clinical features of primary aldosteronism\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    On admission, the patient is treated with KCl and volume expanded with intravenous one-half isotonic saline (containing 77 meq of sodium per liter) at a rate of 125 mL per hour. The next day, repeat laboratory tests are obtained:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;Plasma sodium &nbsp;= &nbsp;137",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma potassium &nbsp;= &nbsp;3.1",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma chloride &nbsp;= &nbsp;95",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma bicarbonate &nbsp;= &nbsp;28",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Arterial pH &nbsp;= &nbsp;7.46",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;Urine sodium &nbsp;= &nbsp;12",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Urine potassium &nbsp;= &nbsp;38",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"   </p>",
"   <p>",
"    &nbsp;A. &nbsp;What diagnosis is suggested by the fall in sodium excretion despite the administration of a saline solution?",
"   </p>",
"   <p>",
"    Because of concern over fluid overload, the patient is switched to intravenous dextrose in water containing 20 meq of KCl per liter. Plasma potassium measured 3 h later has fallen to 2.7",
"    <span class=\"nowrap\">",
"     meq/L.",
"    </span>",
"   </p>",
"   <p>",
"    &nbsp;A. &nbsp;How do you account for this change? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/17/5402?source=see_link\">",
"     \"Causes of hypokalemia\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CASE 3",
"    </span>",
"    &nbsp;&mdash;&nbsp;A previously healthy 34 year-old man is seen for a routine physical examination. The only pertinent history is a family history of stones. He denies any gastrointestinal or renal disease. Initial laboratory findings include:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;BUN &nbsp;= &nbsp;15",
"    <span class=\"nowrap\">",
"     mg/dL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma creatinine &nbsp;= &nbsp;1.0",
"    <span class=\"nowrap\">",
"     mg/dL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma sodium &nbsp;= &nbsp;137",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma potassium &nbsp;= &nbsp;3.1",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma chloride &nbsp;= &nbsp;114",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma bicarbonate &nbsp;= &nbsp;13",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Arterial pH &nbsp;= &nbsp;7.28",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;Arterial PCO2 &nbsp;= &nbsp;28 mmHg",
"   </p>",
"   <p>",
"    &nbsp;A. &nbsp;What is the acid-base disorder? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/41/27288?source=see_link\">",
"     \"Simple and mixed acid-base disorders\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    &nbsp;B. &nbsp;What are the two most common causes of this combined electrolyte disturbance? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/9/9366?source=see_link\">",
"     \"Evaluation of the patient with hypokalemia\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    &nbsp;C. &nbsp;What urinary tests would help to distinguish between these disorders? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/44/18120?source=see_link\">",
"     \"Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    &nbsp;D. &nbsp;In comparison to the rate of acid generation from the metabolism of dietary proteins, what is the rate of urinary acid excretion in stable patients with distal renal tubular acidosis? Where will the extra acid go and how might this relate to the development of kidney stones? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/26/23973?source=see_link\">",
"     \"Nephrolithiasis in renal tubular acidosis\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    &nbsp;E. &nbsp;What is the relation between acid production and acid excretion in stable untreated proximal renal tubular acidosis?",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7248 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-41.78.124.10-AF412BCB0E-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22834=[""].join("\n");
var outline_f22_19_22834=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      CASE 1",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CASE 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CASE 3",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/13/5338?source=related_link\">",
"      Approach to the patient with hypertension and hypokalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/5/33882?source=related_link\">",
"      Causes and evaluation of hyperkalemia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/17/5402?source=related_link\">",
"      Causes of hypokalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37911?source=related_link\">",
"      Clinical features of primary aldosteronism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/44/18120?source=related_link\">",
"      Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9930?source=related_link\">",
"      Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/9/9366?source=related_link\">",
"      Evaluation of the patient with hypokalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/26/23973?source=related_link\">",
"      Nephrolithiasis in renal tubular acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/41/27288?source=related_link\">",
"      Simple and mixed acid-base disorders",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_19_22835="Pegaptanib: Patient drug information";
var content_f22_19_22835=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Pegaptanib: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/54/42851?source=see_link\">",
"     see \"Pegaptanib: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F206719\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Macugen&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F2973204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Macugen&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016078\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691949",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat macular degeneration.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016077\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702685",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to pegaptanib or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703156",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an eye infection.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016082\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698504",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your eye pressure checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016083\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       More eye pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698044",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye infection.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698045",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blurred eyesight. Use care when driving or doing other tasks that call for clear eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016085\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016080\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695993",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the eye.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016081\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor for an office visit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016087\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11243 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.25.216.6-12D3B89698-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22835=[""].join("\n");
var outline_f22_19_22835=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206719\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2973204\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016078\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016077\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016082\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016083\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016085\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016080\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016081\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016087\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?41/54/42851?source=related_link\">",
"      Pegaptanib: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_19_22836="Thoracic dermatomes";
var content_f22_19_22836=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F53938&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F53938&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 559px\">",
"   <div class=\"ttl\">",
"    Thoracic dermatomes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 539px; height: 447px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts the thoracic dermatomes, which are bands of skin that are supplied by the thoracic nerves of the spine.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22836=[""].join("\n");
var outline_f22_19_22836=null;
var title_f22_19_22837="Gemifloxacin: Patient drug information";
var content_f22_19_22837=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Gemifloxacin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/60/12231?source=see_link\">",
"     see \"Gemifloxacin: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F175816\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Factive&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F4799816\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Factive&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10018252\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700791",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of tendons getting irritated and tearing. The chance is greater in people over the age of 60; heart, kidney, or lung transplant patients; or people taking steroid drugs. Call your doctor right away if you have pain in the back of the ankle or joint pain or swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700299",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you have myasthenia gravis. Very bad effects may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10018254\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bacterial infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10018253\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702195",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to gemifloxacin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703760",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had tendons get irritated or torn when taking this drug or an alike drug in the past.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10018258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697296",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have low potassium levels or if you are taking a water pill, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a blood thinner, have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696840",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take antacids, iron, didanosine, or multivitamins within 4 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your use of caffeine (for example, tea, coffee, cola) and chocolate. Use with this drug may cause nervousness, shakiness, and a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10018259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698007",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea). Yogurt or probiotics may help. You may get these products at health food stores or in some pharmacies.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698369",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tendons may rarely get irritated and tear.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10018261\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698993",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Pain in back of the ankle.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698967",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Joint pain or swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10018256\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow tablet whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10018257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10018262\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10018263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11176 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.66.252.144-C264CC6E5B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22837=[""].join("\n");
var outline_f22_19_22837=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F175816\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4799816\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018252\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018254\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018253\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018258\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018259\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018261\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018256\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018257\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018262\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018263\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?11/60/12231?source=related_link\">",
"      Gemifloxacin: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_19_22838="Imaging of pneumothorax";
var content_f22_19_22838=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Imaging of pneumothorax",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/19/22838/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/19/22838/contributors\">",
"     Paul Stark, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/19/22838/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/19/22838/contributors\">",
"     Nestor L Muller, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/19/22838/contributors\">",
"     Steven A Sahn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/19/22838/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/19/22838/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/19/22838/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumothorax refers to gas within the pleural space [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Its clinical manifestations are widely variable. Small pneumothoraces can be asymptomatic and self-limited, but need to be monitored for progression. Large pneumothoraces can cause hypoventilation, hypoxemia,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hemodynamic instability. If such pneumothoraces are not promptly treated, progression to cardiac arrest and death is possible.",
"   </p>",
"   <p>",
"    Radiographic imaging of a pneumothorax is reviewed here. The causes and management of a pneumothorax are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=see_link\">",
"     \"Primary spontaneous pneumothorax in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/35/24121?source=see_link\">",
"     \"Secondary spontaneous pneumothorax in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26873514\">",
"    <span class=\"h1\">",
"     IDENTIFYING A PNEUMOTHORAX",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first-line imaging modalities used to identify a pneumothorax are chest radiography and computed tomography (CT). While some investigators have reported using ultrasound to diagnose pneumothorax, particularly in bedridden patients, ultrasound is not a preferred modality for imaging the chest.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26874535\">",
"    <span class=\"h2\">",
"     Chest radiographs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main feature of a pneumothorax on a chest radiograph is a white visceral pleural line, which is separated from the parietal pleura by a collection of gas (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56589 graphicRef70484 \" href=\"UTD.htm?26/56/27528\">",
"     image 1A-B",
"    </a>",
"    ). In most cases, no pulmonary vessels are visible beyond the visceral pleural line (the collection of pleural gas is avascular). A pneumothorax may be identified on an upright, supine, or lateral decubitus chest radiograph. The lateral decubitus view tends to be the most sensitive, while the supine view is the least sensitive.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Upright",
"      </strong>",
"      &ndash; In an upright patient with a pneumothorax, most pleural gas accumulates in an apicolateral location (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef88943 \" href=\"UTD.htm?23/21/23891\">",
"       image 2",
"      </a>",
"      ). The visceral pleural line appears either straight or convex towards the chest wall. As little as 50 mL of pleural gas may be visible on a chest radiograph [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/4\">",
"       4",
"      </a>",
"      ]. Although a pneumothorax is generally accompanied by a considerable loss of lung volume, the collapsed lung preserves its transradiancy because hypoxic vasoconstriction diminishes the blood flow to the collapsed lung.",
"      <br/>",
"      <br/>",
"      The value of upright expiratory chest radiographs in detecting pneumothoraces has been grossly overstated. In one study, inspiratory and expiratory upright chest radiographs detected pneumothorax with equal sensitivity [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/5\">",
"       5",
"      </a>",
"      ]. These findings, combined with the limitations of expiratory radiographs, have led us to recommend only inspiratory imaging for the initial examination of a potential pneumothorax in our clinical practice.",
"     </li>",
"     <li>",
"      <strong>",
"       Supine",
"      </strong>",
"      &ndash; In a supine patient with a pneumothorax, most pleural gas accumulates in a subpulmonic location. Gas in this location outlines the anterior pleural reflection, the costophrenic sulcus (creating the &ldquo;deep sulcus&rdquo; sign), and the anterolateral border of the mediastinum (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef53642 \" href=\"UTD.htm?6/42/6821\">",
"       image 3",
"      </a>",
"      ). In rare instances, pleural gas can also accumulate in the phrenicovertebral sulcus. The visceral pleural line may be seen at the lung base and has a concave contour. Approximately 500 mL of pleural gas are needed for definitive diagnosis of a pneumothorax on a supine chest radiograph [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/4\">",
"       4",
"      </a>",
"      ]. The transradiancy and size of the entire hemithorax may be increased on the side of a pneumothorax.",
"      <br/>",
"      <br/>",
"      A hydropneumothorax (including sero-, hemo-, pyo-, and chylothoraces) in a supine patient can produce a veil&ndash;like opacity, more opaque than a pure pneumothorax and less opaque than a pure hydrothorax (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef58226 graphicRef80846 \" href=\"UTD.htm?11/57/12185\">",
"       image 4A-B",
"      </a>",
"      ). This is explained by en face imaging of the pleural effusion posteriorly and intrapleural gas anteriorly, with its attending summation effect (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51925 \" href=\"UTD.htm?37/21/38224\">",
"       image 5",
"      </a>",
"      ). Occasionally, the visceral pleural line of a partially collapsed lung floating on the dependent pleural effusion can be seen, facilitating the diagnosis.",
"     </li>",
"     <li>",
"      <strong>",
"       Lateral decubitus",
"      </strong>",
"      &ndash; A pneumothorax can be most easily detected with a lateral decubitus view. In this position, most pleural gas accumulates in the non-dependent lateral location. The visceral pleural line appears either straight or convex towards the chest wall. As little as 5 mL of pleural gas may be visible on a lateral decubitus chest radiograph [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19124390\">",
"    <span class=\"h2\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) scanning is the most accurate imaging modality for the detection of pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/6\">",
"     6",
"    </a>",
"    ]. Even small amounts of intrapleural gas, atypical collections of pleural gas, and loculated pneumothoraces can be identified by CT. In addition, complex pleural pathology (eg, pleural effusion, pneumothorax) can be optimally displayed by CT scanning (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef88944 \" href=\"UTD.htm?29/22/30050\">",
"     image 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef88945 \" href=\"UTD.htm?10/18/10534\">",
"     image 7",
"    </a>",
"    ). Pleural interventional procedures are vastly facilitated by CT guidance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26874124\">",
"    <span class=\"h2\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound of the chest is sometimes used to evaluate a patient for pneumothorax. This is most common in situations in which the diagnosis must be made emergently at the bedside, such as an ICU patient or a trauma patient in the emergency department, so-called point-of-care ultrasound [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/30/7658?source=see_link&amp;anchor=H30174609#H30174609\">",
"     \"Emergency ultrasound in adults with abdominal and thoracic trauma\", section on 'Pneumothorax and hemothorax'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/21/23898?source=see_link&amp;anchor=H4933849#H4933849\">",
"     \"Initial evaluation and management of penetrating thoracic trauma in adults\", section on 'Thoracic ultrasound'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The ultrasonographic signs of a pneumothorax reflect the absence of a normal interface between the lung and pleura. Signs of a normal lung and pleural interface include &ldquo;lung sliding&rdquo;, due to sliding of the visceral and parietal pleura relative to each other, and &ldquo;B lines&rdquo;, also called a comet tail. B lines consist of three to four perpendicular lines that originate at the interface between the visceral and parietal pleurae and extend to the bottom aspect of the ultrasonographic image (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71143 \" href=\"UTD.htm?13/39/13951\">",
"     image 8",
"    </a>",
"    ). In addition, smooth, horizontal lines are seen above the pleural line and grainy echoes below. In the presence of a pneumothorax, smooth, horizontal echogenic lines are seen above and below the pleural line. The absence of lung sliding and B lines allows for the diagnosis of pneumothorax in real time with focused ultrasound at the point of care [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/10,11\">",
"     10,11",
"    </a>",
"    ], although the role of operator experience has not been fully examined. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26408?source=see_link&amp;anchor=H165837042#H165837042\">",
"     \"Thoracic ultrasound: Indications, advantages, and technique\", section on 'Identification of pneumothorax'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The accuracy of thoracic ultrasound for the detection of pneumothorax has been examined in a number of studies [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/6,8,12,13\">",
"     6,8,12,13",
"    </a>",
"    ], including a meta-analysis of eight studies that compared thoracic ultrasound with chest radiography [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/12\">",
"     12",
"    </a>",
"    ]. The sensitivities of ultrasound and chest radiography (supine and semi-erect) were 91 and 50 percent, respectively. The low sensitivity of chest radiography was likely due to the supine position of patients in seven of the eight studies. Both ultrasound and chest radiography demonstrated a high specificity, from 98 to 99 percent. Thus, ultrasound appears more sensitive than supine chest radiography for detecting a pneumothorax. (See",
"    <a class=\"local\" href=\"#H26874535\">",
"     'Chest radiographs'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In a series that compared thoracic ultrasound with chest CT, ultrasonography by a radiologist detected 80 percent of the pneumothoraces detected by CT [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26873522\">",
"    <span class=\"h1\">",
"     SIZE OF PNEUMOTHORAX",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accurate estimation of the size of a pneumothorax is difficult. The average interpleural distance (AID) approximates the size of a pneumothorax from a frontal chest radiograph by taking the sum of the distances (measured in millimeters) between the ribs and the visceral pleura at the apical, midthoracic, and basal levels, then dividing the sum by three (",
"    <a class=\"graphic graphic_figure graphicRef57217 \" href=\"UTD.htm?7/29/7647\">",
"     figure 1",
"    </a>",
"    ). An alternative method, called the Light Index, uses the following equation to estimate the size of a pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    Percent pneumothorax = [100 &ndash; (average lung",
"    <span class=\"nowrap\">",
"     diameter3/average",
"    </span>",
"    hemithorax diameter3)] x 100",
"   </p>",
"   <p>",
"    Both the AID and the Light Index express the size of the pneumothorax as the percent pneumothorax. The Light Index better correlates with the amount of pneumothorax gas removed by suction [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Such methods are difficult to apply and tend to underestimate the size of a pneumothorax. As a result, some clinicians tend to describe a pneumothorax as large or small, rather than utilize percentages. British Thoracic Society guidelines define a pneumothorax as small if the distance from chest wall to the visceral pleural line is less than 2 cm or large if the distance from the chest wall to the visceral pleural line is 2 cm or greater [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/16\">",
"     16",
"    </a>",
"    ]. Some clinicians prefer 3 cm laterally and 4 cm apically as the threshold to distinguish small and large pneumothoraces.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TYPES OF PNEUMOTHORAX",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging may provide important clues about the type of pneumothorax that exists. However, imaging alone is seldom sufficient to determine the type of pneumothorax. The clinical context always needs to be considered along with the imaging findings.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Simple pneumothorax",
"      </strong>",
"      &ndash; With a simple pneumothorax, the pleural pressure in the affected hemithorax remains subatmospheric and is only slightly more positive than the pleural pressure in the contralateral hemithorax. A simple pneumothorax usually has only modest repercussions unless the patient has limited respiratory reserve or is being mechanically ventilated. Radiographically, simple pneumothoraces tend to be small and without mediastinal shift to the contralateral side.",
"     </li>",
"     <li>",
"      <strong>",
"       Tension pneumothorax",
"      </strong>",
"      &ndash; With a tension pneumothorax, the pleural pressure in the affected hemithorax exceeds atmospheric pressure, particularly during expiration. This is frequently the result of a \"check valve\" mechanism that facilitates the ingress of gas into the pleural space during inspiration, but blocks the egress of gas from the pleural space during expiration. The results are the accumulation of gas, the build-up of pressure within the pleural space, and eventually respiratory failure from compression of the contralateral normal lung. Radiographically, tension pneumothorax shows a distinct shift of the mediastinum to the contralateral side and flattening or inversion of the ipsilateral hemidiaphragm (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef73669 graphicRef61900 \" href=\"UTD.htm?35/12/36041\">",
"       image 9A-B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Open pneumothorax",
"      </strong>",
"      &ndash; Open pneumothorax occurs when a traumatic chest wall defect persists, through which ambient air enters the pleural space during inspiration (ie, a \"sucking wound\"). As a result, the mediastinum shifts toward the normal hemithorax and the lung within the injured hemithorax remains collapsed. During expiration, air exits the pleural space through the chest wall defect and the mediastinum swings back toward the injured hemithorax. Expiratory air from the normal lung (ie, &ldquo;pendulum air&rdquo;) fills the collapsed lung. The &ldquo;mediastinal flutter\" may cause respiratory failure. Radiographically, an open pneumothorax is characterized by a visible chest wall defect and by massive expiratory mediastinal shift towards the injured side: this mediastinal behavior is different from tension pneumothorax where the expiratory shift of the mediastinum occurs towards the normal lung, resulting from air-trapping in the affected pleural space.",
"     </li>",
"     <li>",
"      <strong>",
"       Pneumothorax ex vacuo",
"      </strong>",
"      &ndash; This rare type of pneumothorax forms adjacent to an atelectatic lobe (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef81968 \" href=\"UTD.htm?21/8/21637\">",
"       image 10",
"      </a>",
"      ). It is seen preferentially with atelectasis of the right upper lobe and is the result of rapid atelectasis producing an abrupt decrease in the intrapleural pressure with subsequent release of nitrogen from pleural capillaries. Treatment consists of bronchoscopy rather than chest tube drainage. Radiographically, pneumothorax ex vacuo is suggested when an atelectatic lobe or lung, particularly right upper lobe atelectasis, is surrounded by a focal pneumothorax. A similar presentation can occur in patients with visceral pleural thickening and a \"trapped lung\" following drainage of an effusion [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/17\">",
"       17",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/62/4072?source=see_link\">",
"       \"Diagnosis and management of pleural causes of unexpandable lung\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Bilateral postoperative pneumothorax",
"      </strong>",
"      &ndash; Bilateral pneumothoraces have been described after cardiac surgery, particularly in recipients of heart&ndash;lung transplants. They are a consequence of extensive mediastinal dissection disrupting the anterior junction line, formed by the parietal pleural reflections of both hemithoraces, allowing a unilateral pneumothorax to propagate to the contralateral hemithorax [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/18\">",
"       18",
"      </a>",
"      ]. A single thoracostomy tube is able to evacuate both pleural cavities. This type of pneumothorax has been dubbed &ldquo;buffalo chest,&rdquo; since these animals have pleural spaces that communicate anteriorly and, as a result, they are susceptible to bilateral pneumothorax [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CONDITIONS MIMICKING PNEUMOTHORAX",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous conditions can mimic a pneumothorax radiographically.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Bullae",
"      </strong>",
"      &ndash; Large subpleural bullae can mimic a loculated pneumothorax (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef82207 \" href=\"UTD.htm?20/54/21349\">",
"       image 11",
"      </a>",
"      ). Both bullae and pneumothoraces usually have a visceral pleural contour that is either straight or convex laterally, but only bullae typically have a medial border that is concave to the chest wall [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/20\">",
"       20",
"      </a>",
"      ]. Exceptions to this distinction occur with subpulmonic collections of gas, loculated collections of gas, or pleural adhesions (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef59597 graphicRef71341 graphicRef58631 graphicRef70959 \" href=\"UTD.htm?37/0/37898\">",
"       image 12A-D",
"      </a>",
"      ). Bullae and pneumothoraces can occasionally coexist [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Trauma",
"      </strong>",
"      &ndash; The stomach can herniate into the chest following traumatic rupture of the left hemidiaphragm and a gas-filled, intrathoracic stomach may be mistaken for a loculated pneumothorax (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef76272 \" href=\"UTD.htm?39/58/40879\">",
"       image 13",
"      </a>",
"      ). This can be disastrous if drainage with a thoracostomy tube is attempted.",
"     </li>",
"     <li>",
"      <strong>",
"       Skin folds",
"      </strong>",
"      &ndash; A skin fold can generally be distinguished from a pneumothorax by careful evaluation of the radiograph. Skin folds frequently extend beyond the rib cage, stop short of the ribs,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      gradually increase in opacity with an abrupt drop&ndash;off at the edge of the image. Blood vessels often extend beyond the skin fold [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22838/abstract/21\">",
"       21",
"      </a>",
"      ]. Skin folds can also be differentiated from a pneumothorax by their attenuation profile, forming a negative black Mach band instead of the white visceral pleural line. Mach bands are a retinal phenomenon resulting from lateral inhibition of receptors induced by an abrupt transition between a white and a black interface, with subsequent visual generation of edge enhancement. This can lead to the formation of a positive (white) or a negative (black) Mach band.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/30/40418?source=see_link\">",
"       \"Patient information: Pneumothorax (collapsed lung) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26873418\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pneumothorax refers to gas within the pleural space. Its clinical manifestations are widely variable. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The first-line imaging modalities used to identify a pneumothorax are chest radiography and computed tomography. Computed tomography is definitive, but generally necessary only in complex cases. (See",
"      <a class=\"local\" href=\"#H26873514\">",
"       'Identifying a pneumothorax'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The main feature of a pneumothorax on a chest radiograph is a white visceral pleural line, which is separated from the parietal pleura by a collection of gas. In most cases, no pulmonary vessels are visible beyond the visceral pleural line. A pneumothorax may be identified on an upright, supine, or lateral decubitus chest radiograph. (See",
"      <a class=\"local\" href=\"#H26874535\">",
"       'Chest radiographs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Two signs have been identified by chest ultrasound that when present appear to rule out pneumothorax, the &ldquo;sliding lung&rdquo; and &ldquo;B lines&rdquo; (also called the \"comet tail\" artifact). (See",
"      <a class=\"local\" href=\"#H26874124\">",
"       'Ultrasound'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26408?source=see_link&amp;anchor=H165837042#H165837042\">",
"       \"Thoracic ultrasound: Indications, advantages, and technique\", section on 'Identification of pneumothorax'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Clinicians tend to describe a pneumothorax as large or small, rather than utilize a percentage scale. (See",
"      <a class=\"local\" href=\"#H26873522\">",
"       'Size of pneumothorax'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Imaging may provide important clues about the etiology and pathophysiology of pneumothorax. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Types of pneumothorax'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Numerous conditions can mimic a pneumothorax radiographically, including bullae, skin folds, and stomach herniation into the chest following traumatic rupture of the left hemidiaphragm. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Conditions mimicking pneumothorax'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/1\">",
"      O'Connor AR, Morgan WE. Radiological review of pneumothorax. BMJ 2005; 330:1493.",
"     </a>",
"    </li>",
"    <li>",
"     Stark, P. The Pleura. In: Radiology, Diagnosis, Imaging, Intervention, Taveras and Ferrucci (Ed), Lippincott, Philadelphia 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/3\">",
"      Greene, R, McLoud, TC, Stark, P. Pneumothorax. Semin Roentgenol 1977; 4:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/4\">",
"      Carr JJ, Reed JC, Choplin RH, et al. Plain and computed radiography for detecting experimentally induced pneumothorax in cadavers: implications for detection in patients. Radiology 1992; 183:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/5\">",
"      Seow A, Kazerooni EA, Pernicano PG, Neary M. Comparison of upright inspiratory and expiratory chest radiographs for detecting pneumothoraces. AJR Am J Roentgenol 1996; 166:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/6\">",
"      Jalli R, Sefidbakht S, Jafari SH. Value of ultrasound in diagnosis of pneumothorax: a prospective study. Emerg Radiol 2013; 20:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/7\">",
"      Kirkpatrick AW, Sirois M, Laupland KB, et al. Hand-held thoracic sonography for detecting post-traumatic pneumothoraces: the Extended Focused Assessment with Sonography for Trauma (EFAST). J Trauma 2004; 57:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/8\">",
"      Wilkerson RG, Stone MB. Sensitivity of bedside ultrasound and supine anteroposterior chest radiographs for the identification of pneumothorax after blunt trauma. Acad Emerg Med 2010; 17:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/9\">",
"      Mandavia DP, Joseph A. Bedside echocardiography in chest trauma. Emerg Med Clin North Am 2004; 22:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/10\">",
"      Moore CL, Copel JA. Point-of-care ultrasonography. N Engl J Med 2011; 364:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/11\">",
"      Lichtenstein D. General ultrasound in the critically ill. Springer 2005; 105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/12\">",
"      Raja AS, Jacobus CH. How accurate is ultrasonography for excluding pneumothorax? Ann Emerg Med 2013; 61:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/13\">",
"      Alrajhi K, Woo MY, Vaillancourt C. Test characteristics of ultrasonography for the detection of pneumothorax: a systematic review and meta-analysis. Chest 2012; 141:703.",
"     </a>",
"    </li>",
"    <li>",
"     Light, RW. Pneumothorax. In: Pleural Diseases, 3rd, Light, RW (Eds), Williams and Wilkins, Baltimore 1990. p.242.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/15\">",
"      Noppen M, Alexander P, Driesen P, et al. Quantification of the size of primary spontaneous pneumothorax: accuracy of the Light index. Respiration 2001; 68:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/16\">",
"      MacDuff A, Arnold A, Harvey J, BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 Suppl 2:ii18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/17\">",
"      Woodring JH, Baker MD, Stark P. Pneumothorax ex vacuo. Chest 1996; 110:1102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/18\">",
"      Engeler CE, Olson PN, Engeler CM, et al. Shifting pneumothorax after heart-lung transplantation. Radiology 1992; 185:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/19\">",
"      Chan F, Stark P. Bilateral pneumothoraces after coronary bypass suregery &ndash; a case of &ldquo;buffalo chest&rdquo;. Clin Intensive Care 1997; 8:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/20\">",
"      Jacobson, F, Stark, P. Pneumothorax or giant bullae? Clin Intensive Care 1992; 3:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22838/abstract/21\">",
"      Stark, P, Eber, C. Pneumothorax or skin fold?. Clin Intensive Care 1993; 4:45.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6981 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-27.109.116.13-23EAA62341-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22838=[""].join("\n");
var outline_f22_19_22838=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26873418\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26873514\">",
"      IDENTIFYING A PNEUMOTHORAX",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26874535\">",
"      Chest radiographs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19124390\">",
"      Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26874124\">",
"      Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26873522\">",
"      SIZE OF PNEUMOTHORAX",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TYPES OF PNEUMOTHORAX",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CONDITIONS MIMICKING PNEUMOTHORAX",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26873418\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6981\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6981|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/52/41797\" title=\"diagnostic image 1A\">",
"      Chest Xray of pneumothorax after stab wound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/61/40912\" title=\"diagnostic image 1B\">",
"      Bilateral pneumothoraces CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/21/23891\" title=\"diagnostic image 2\">",
"      Chest radiograph of hydropneumothorax",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/42/6821\" title=\"diagnostic image 3\">",
"      Bilateral pneumothoraces PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/20/33090\" title=\"diagnostic image 4A\">",
"      Hemopneumothorax I PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/24/6534\" title=\"diagnostic image 4B\">",
"      Hemopneumothorax II PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/21/38224\" title=\"diagnostic image 5\">",
"      Atypical hydropneumothorax CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/22/30050\" title=\"diagnostic image 6\">",
"      Hydropneumothorax in rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/18/10534\" title=\"diagnostic image 7\">",
"      Bullous lung disease and pneumothorax",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/39/13951\" title=\"diagnostic image 8\">",
"      B lines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?35/19/36149\" title=\"diagnostic image 9A\">",
"      Tension pneumothorax I PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?9/1/9237\" title=\"diagnostic image 9B\">",
"      Tension pneumothorax II PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/8/21637\" title=\"diagnostic image 10\">",
"      Pneumothorax ex vacuo PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/54/21349\" title=\"diagnostic image 11\">",
"      Giant bilateral bullae PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/22/24930\" title=\"diagnostic image 12A\">",
"      Atypical pneumothorax CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/47/29430\" title=\"diagnostic image 12B\">",
"      Atypical pneumothorax PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/47/30449\" title=\"diagnostic image 12C\">",
"      Loculated pneumothorax CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/5/7251\" title=\"diagnostic image 12D\">",
"      Trapped lung hematoma CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/58/40879\" title=\"diagnostic image 13\">",
"      Hernia mimicking ptx",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6981|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/29/7647\" title=\"figure 1\">",
"      Average intrapleural distance",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/62/4072?source=related_link\">",
"      Diagnosis and management of pleural causes of unexpandable lung",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/30/7658?source=related_link\">",
"      Emergency ultrasound in adults with abdominal and thoracic trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/21/23898?source=related_link\">",
"      Initial evaluation and management of penetrating thoracic trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/30/40418?source=related_link\">",
"      Patient information: Pneumothorax (collapsed lung) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=related_link\">",
"      Primary spontaneous pneumothorax in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/35/24121?source=related_link\">",
"      Secondary spontaneous pneumothorax in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26408?source=related_link\">",
"      Thoracic ultrasound: Indications, advantages, and technique",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_19_22839="Psoas abscess";
var content_f22_19_22839=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Psoas abscess",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/19/22839/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/19/22839/contributors\">",
"     Denis Spelman, MBBS, FRACP, FRCPA, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/19/22839/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/19/22839/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/19/22839/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/19/22839/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/19/22839/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A psoas (or iliopsoas) abscess is a collection of pus in the iliopsoas muscle compartment [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/1\">",
"     1",
"    </a>",
"    ]. It may arise via contiguous spread from adjacent structures or by the hematogenous route from a distant site. The incidence is rare but the frequency of this diagnosis has increased with the use of computed tomography (CT), prior to which most cases were diagnosed at post mortem [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/2\">",
"     2",
"    </a>",
"    ]. The anatomy, pathogenesis, microbiology, clinical manifestations, diagnosis, and treatment of psoas abscess will be reviewed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Understanding the clinical manifestations, complications, and management of psoas abscess requires knowledge of the anatomy of the psoas muscle and its adjacent structures.",
"   </p>",
"   <p>",
"    The psoas muscle arises from the transverse processes and the lateral aspects of the vertebral bodies between the twelfth thoracic and the fifth lumbar vertebrae. From this origin it courses downward across the pelvic brim, passes deep to the inguinal ligament and anterior to the hip joint capsule to form a tendon that inserts into the lesser trochanter of the femur. The iliacus muscle joins the psoas to insert via the same tendon. The iliacus and psoas muscles are the main hip flexors.",
"   </p>",
"   <p>",
"    The psoas and iliacus are sometimes considered together as the iliopsoas muscle, located in an extraperitoneal space called the iliopsoas compartment. The tendon is separated from the hip capsule by the iliopsoas bursa. This bursa is in communication with the hip joint space in up to 15 percent of persons, which may facilitate spread of infection between these sites.",
"   </p>",
"   <p>",
"    The psoas muscle is situated near a number of important anatomical structures including the vertebral bodies, the abdominal aorta, the sigmoid colon, the appendix, the hip joint, and iliac lymph nodes. Infection may spread directly between these structures and the psoas muscle.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psoas abscesses may be divided into primary and secondary abscesses according to the pathogenesis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Primary abscess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary psoas abscess occurs as a result of hematogenous or lymphatic seeding from a distant site (which may be occult) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Risk factors include diabetes, intravenous drug use, human immunodeficiency virus (HIV) infection, renal failure, and other forms of immunosuppression [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Trauma and hematoma formation can predispose to development of psoas abscess [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Primary psoas abscesses tend to occur in children and young adults [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/2,3,5\">",
"     2,3,5",
"    </a>",
"    ]. They are more common in tropical and developing countries. In Asia and Africa, 99 percent of iliopsoas abscesses are primary; in Europe and North America 17 to 61 percent are primary [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/3\">",
"     3",
"    </a>",
"    ]. It may be difficult to distinguish between primary and secondary abscesses in some circumstances [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Secondary abscess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Secondary psoas abscess occurs as a result of direct spread of infection to the psoas muscle from an adjacent structure. It may be uncertain whether involvement of a contiguous structure is a cause or a consequence of the psoas muscle abscess [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for secondary abscess include trauma and instrumentation in the inguinal region, lumbar spine, or hip region [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/7-10\">",
"     7-10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Adjacent structures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Involved structures may include the vertebral bodies and discs, the hip joint, the gastrointestinal tract, the genitourinary tract, vascular structures, and other sites [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/2,7\">",
"     2,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vertebrae &mdash; Bony sites are the most frequent contiguous infected site (39.5 percent in one report) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/5\">",
"       5",
"      </a>",
"      ]. Vertebral osteomyelitis or discitis can give rise to psoas abscess when infection spreads from bone and perforates the psoas sheath. Psoas abscess may be accompanied by involvement of the epidural space with epidural abscess formation due to spread of infection from the vertebral body [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/11\">",
"       11",
"      </a>",
"      ]. Vertebral osteomyelitis with a psoas abscess has been reported as a complication of epidural catheter use [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/12\">",
"       12",
"      </a>",
"      ]. Demonstration of a psoas abscess should prompt investigation for a possible vertebral source [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/13\">",
"       13",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/28/22985?source=see_link\">",
"       \"Vertebral osteomyelitis and discitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/46/42726?source=see_link\">",
"       \"Hematogenous osteomyelitis in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hip arthroplasty &mdash; Psoas abscess can occur in association with total hip arthroplasty [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/7\">",
"       7",
"      </a>",
"      ]. In one series of 106 patients admitted with hip arthroplasty infection, psoas abscess was observed in 12 percent of cases. Hematogenous infection and history of neoplasm were predictors of psoas abscess [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/14\">",
"       14",
"      </a>",
"      ]. However, the frequency of associated psoas infections is probably much lower in situations where the diagnosis of hip arthroplasty infection is promptly identified and treated.",
"     </li>",
"     <li>",
"      Gastrointestinal tract &mdash; Hip pain in patients with Crohn's disease should prompt consideration of psoas abscess, particularly in the setting of severe ileocolitis [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/1,15\">",
"       1,15",
"      </a>",
"      ]. The incidence of psoas abscess in Crohn's disease has been estimated to be between 0.4 and 4.3 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/16\">",
"       16",
"      </a>",
"      ]. Diagnosis can be delayed if hip pain is initially attributed to arthritis (a well described extraintestinal manifestation of Crohn's disease).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Psoas abscess has also been described in the setting of appendicitis, colorectal cancer, ulcerative colitis, and following abdominal surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/2,3,5,17\">",
"     2,3,5,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aorta &mdash; Psoas abscess can occur in patients with an infected aortic aneurysm; this may be complicated by aortic rupture [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/18,19\">",
"       18,19",
"      </a>",
"      ]. In a series of 40 cases of infected aortic aneurysms, 20 percent were complicated by psoas abscess [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/18\">",
"       18",
"      </a>",
"      ]. Psoas abscess has also been described in the setting of aorto-duodenal fistula and infected stent graft material [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/19-21\">",
"       19-21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Genitourinary tract &mdash; Psoas abscess can occur as a complication of renal surgery, extracorporeal shock wave lithotripsy, and nephrectomy [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/22\">",
"       22",
"      </a>",
"      ]. Ruptured renal abscess has also been associated with psoas abscess. Among Klebsiella pneumoniae psoas abscesses reported from Taiwan, 43 percent had concurrent urinary infection. Xanthogranulomatous pyelonephritis, an uncommon form of pyelonephritis, has also been associated with psoas abscess [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/23\">",
"       23",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/31/29176?source=see_link\">",
"       \"Invasive liver abscess syndrome caused by Klebsiella pneumoniae\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/26/16804?source=see_link\">",
"       \"Xanthogranulomatous pyelonephritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other sites &mdash; A ruptured abscess of the pancreas can result in psoas abscess. Instrumentation involving the inguinal or lumbar region can also be complicated by psoas abscesses [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The microbiology of psoas abscess varies with geography and pathogenesis of infection (eg, whether the process is primary or secondary to infection at an adjacent site).",
"   </p>",
"   <p>",
"    Primary psoas abscesses are most frequently due to infection with a single organism [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/11\">",
"     11",
"    </a>",
"    ]. Mycobacterium tuberculosis is a frequent cause of psoas abscess in regions where tuberculosis is common [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The most common bacterial cause is Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA); in one study, S. aureus was implicated in 88 percent of cases (followed by streptococci and E. coli; 4.9 and 2.8 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/3,5,17,24,25\">",
"     3,5,17,24,25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/49/37656?source=see_link\">",
"     \"Skeletal tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Secondary psoas abscess may be monomicrobial or polymicrobial; in one report of psoas abscesses due to bacterial infection, 55 percent were polymicrobial, and 82 percent of these contained enteric organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/3\">",
"     3",
"    </a>",
"    ]. In another report of psoas abscesses, 21 percent of psoas abscesses reflected polymicrobial infection, including enteric organisms (particularly in the setting of abscesses with gastrointestinal tract origin). Anaerobes were isolated from 15 percent of psoas abscesses in one report [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Klebsiella pneumoniae is an important cause of psoas abscess in Taiwan, especially in patients with diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/26\">",
"     26",
"    </a>",
"    ]. There are reports of psoas abscess caused by S. pneumoniae [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/27\">",
"     27",
"    </a>",
"    ] and Streptobacillus moniliformis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/28\">",
"     28",
"    </a>",
"    ], and in disseminated nocardiosis. Psoas abscess due to Salmonella (mostly non-typhi Salmonella) has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/29\">",
"     29",
"    </a>",
"    ]. Candida albicans has also been described, although rarely [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/31/29176?source=see_link\">",
"     \"Invasive liver abscess syndrome caused by Klebsiella pneumoniae\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16489?source=see_link\">",
"     \"Clinical manifestations and diagnosis of nocardiosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psoas abscesses are more common in males than females [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. The median age of patients is 44 to 58 years in developed countries. However, psoas abscesses tend to occur more frequently among patients &lt;20 years in developing countries than in North America (81 versus 48 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/3,5,17\">",
"     3,5,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Psoas abscess occurs on the right and left sides with roughly equal frequency. Bilateral psoas abscesses are uncommon. In most case series the frequency of bilateral abscesses is 1 to 5 percent; however, some authors have reported bilateral abscesses in up to 30 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/3,11,17,30,31\">",
"     3,11,17,30,31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Signs and symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Signs and symptoms of psoas abscess include back or flank pain, fever, inguinal mass, limp, anorexia, and weight loss [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/1-3,5\">",
"     1-3,5",
"    </a>",
"    ]. Pain is present in up to 91 percent of cases with localization to the back, flank, or lower abdomen, with or without radiation to the hip",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the posterior aspect of the thigh [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/1,3,5,11,22\">",
"     1,3,5,11,22",
"    </a>",
"    ]. Fever is present in up to 75 percent of cases and a psoas abscess may manifest as a fever of unknown origin [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/22,30\">",
"     22,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Psoas abscesses occasionally extend distally and present as a painful or painless mass below the inguinal ligament [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/22\">",
"     22",
"    </a>",
"    ]. When an inguinal mass in a patient with a psoas abscess is painless (ie, a cold abscess), tuberculosis is a more likely cause than a bacterial infection [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/32\">",
"     32",
"    </a>",
"    ]. The mass may rarely mimic inguinal lymphadenopathy or a femoral hernia.",
"   </p>",
"   <p>",
"    Pain is exacerbated when performing movements in which the psoas muscle is stretched or extended; the \"psoas sign\" is pain brought on by extension of the hip. Limitation of hip movement is common and patients frequently prefer to be in a position of less discomfort that includes hip flexion and lumbar lordosis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/32\">",
"     32",
"    </a>",
"    ]. Unlike septic arthritis, hip pain in patients with psoas abscesses is usually diminished with hip flexion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The presenting symptoms may be nonspecific and the onset is often subacute; symptoms may be present for a few weeks and up to six months [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/11\">",
"     11",
"    </a>",
"    ]. Symptoms may have features suggesting other diagnoses such as septic hip arthritis or gastrointestinal or renal tract pathology, leading to delayed diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/2\">",
"     2",
"    </a>",
"    ]. In one study, the median time between the onset of symptoms and diagnosis was 22 days; the interval was &gt;42 days for one-third of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leukocytosis",
"    <span class=\"nowrap\">",
"     (&gt;10,000/mL)",
"    </span>",
"    is observed in up to 83 percent of cases; anemia &lt;11",
"    <span class=\"nowrap\">",
"     g/L",
"    </span>",
"    is frequent (42.6 percent in one series) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/5,11,26\">",
"     5,11,26",
"    </a>",
"    ]. Thrombocytosis is observed less frequently (27 percent of cases) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/5\">",
"     5",
"    </a>",
"    ]. An elevated erythrocyte sedimentation rate may be observed (&gt;50 in 73 percent of cases); the C-reactive protein is often elevated and averaged 189.8 in one series [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/2,26\">",
"     2,26",
"    </a>",
"    ]. Elevated aspartate aminotransferase has also been described (&gt;40 in 38 percent of cases) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of psoas abscess include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Septic shock (about 20 percent of cases in two series) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/26,30\">",
"       26,30",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Deep venous thrombosis due to extrinsic compression of the iliac vein has also been described, as has paralytic bowel ileus [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/34\">",
"       34",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hydronephrosis due to ureteric compression [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/1\">",
"       1",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Bowel ileus [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/2\">",
"       2",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Retroperitoneal and intraperitoneal lesions including inflammation, hematoma, or tumor of the psoas muscle can mimic a psoas abscess, as may retrocecal appendicitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/35\">",
"     35",
"    </a>",
"    ]. However, patients with retrocecal appendicitis typically have pain in the retrovesical pouch during a rectal exam, whereas those with a psoas abscess do not.",
"   </p>",
"   <p>",
"    Enlargement of the iliopsoas bursa (which can communicate with the hip joint) can be difficult to distinguish from a psoas abscess. Infection of adjacent structures not involving the psoas muscle (eg, septic hip arthritis) can also mimic a psoas abscess.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of a psoas abscess may be suspected on clinical grounds and confirmed on imaging studies. Identification of the etiological organism requires culture of blood or aspirated pus or, rarely, surgically obtained tissue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) is the optimal radiographic modality to evaluate for psoas abscess; it provides definitive diagnosis in almost all cases [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/1,5,6,36\">",
"     1,5,6,36",
"    </a>",
"    ]. In most cases an abscess is obvious; other findings may include a focal hypodense lesion, infiltration of surrounding fat, and gas or an air fluid level within the muscle [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/19,36\">",
"     19,36",
"    </a>",
"    ]. Magnetic resonance imaging (MRI) may allow improved definition of soft tissues and adjacent structures, especially visualization of the vertebral bodies [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/1,2,37\">",
"     1,2,37",
"    </a>",
"    ]. Evidence of bony spinal infection should increase suspicion for tuberculosis in the appropriate epidemiologic circumstances.",
"   </p>",
"   <p>",
"    Abdominal plain radiographs may suggest loss of psoas muscle definition, abnormal soft tissue shadows, and the presence of gas, but such findings are often not consistent or definitive [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/2\">",
"     2",
"    </a>",
"    ]. In one study routine abdominal radiography was a poor diagnostic tool in that psoas muscle involvement was indicated in only 14.4 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/5\">",
"     5",
"    </a>",
"    ]. Chest x-ray may demonstrate elevation of the diaphragm or a pleural effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although CT is the modality of choice when a psoas abscess is suspected clinically, a psoas abscess may also be visualized on nuclear imaging used to identify occult foci of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/15,35\">",
"     15,35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/50/12071?source=see_link&amp;anchor=H6#H6\">",
"     \"Approach to imaging modalities in the setting of suspected osteomyelitis\", section on 'Nuclear modalities'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ultrasound has low sensitivity and specificity; bowel gas and the pelvic bone may make ultrasound diagnosis difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/22\">",
"     22",
"    </a>",
"    ]. Although ultrasound imaging may be diagnostic in up to 50 percent of cases, this modality may miss a diffuse phlegmon or small lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/5,14,22,30\">",
"     5,14,22,30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood samples and abscess material should be sent to the microbiology lab for Gram stain and bacterial culture. AFB smear and mycobacterial culture should also be performed when tuberculosis is suspected or when routine Gram staining is negative. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Blood cultures are positive in 41 to 68 percent of cases; the most frequent blood culture isolate is S. aureus [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/3,13\">",
"     3,13",
"    </a>",
"    ]. Culture of abscess material is frequently needed to identify the causative organism. If feasible this material should be obtained prior to initiation of antimicrobial therapy to optimize the culture yield.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biopsy material should be sent for histopathology evaluation as this may be useful for identification of mycobacterial infection as well as an alternative diagnosis such as tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of psoas abscess consists of drainage and prompt initiation of appropriate antibiotic therapy. Secondary abscess also requires management of the adjacent infected focus (such as ruptured viscus, fistula, or infected aortic aneurysm).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Drainage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abscess drainage may be achieved with percutaneous or surgical intervention. Percutaneous drainage (by ultrasound or CT guidance) is an appropriate initial approach; in one study this technique successful in 90 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/1,2,17,38\">",
"     1,2,17,38",
"    </a>",
"    ]. Following needle aspiration a pigtail catheter may be placed in situ to allow further drainage. The percutaneous catheter may be removed when drainage has ceased, the patient's condition has improved, and repeat imaging demonstrates that the drainage has been satisfactory.",
"   </p>",
"   <p>",
"    Surgical drainage may be warranted in the setting of percutaneous drainage failure; there are no studies directly comparing open and percutaneous approaches. Indications for surgical drainage include multiloculated abscesses and significant involvement of an adjacent structure requiring surgical management [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/2,30\">",
"     2,30",
"    </a>",
"    ]. Options for surgical drainage include laparoscopic and open surgical drainage. Advantages of laparoscopy include the extraperitoneal nature of the procedure, the capability to break down loculations, and rapid postoperative recovery [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Open drainage via an extraperitoneal approach was previously the surgical intervention of choice; in one series successful outcomes were described in 97 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/3\">",
"     3",
"    </a>",
"    ]. Open surgical drainage may be warranted in the setting of a multiloculated psoas abscess or an abscess secondary to bowel disease (eg, Crohn's Disease) in which bowel resection may be necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, directed antimicrobial therapy (based on the results of cultures and smears) is preferable to empiric therapy. It is preferable to attempt to make definitive diagnosis before initiating antibiotic therapy. For circumstances in which prompt microbial diagnosis is not feasible, empiric antibiotic therapy should include activity against S. aureus (including activity against MRSA in regions where prevalence is substantial) and enteric organisms (both aerobic and anaerobic enteric flora) (",
"    <a class=\"graphic graphic_table graphicRef64723 \" href=\"UTD.htm?6/51/6972\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antimicrobial therapy should be tailored to culture and susceptibility results. Evidence of mycobacterial infection should prompt management as described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in the HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Parenteral antibiotics should be administered in conjunction with psoas abscess drainage. Antibiotics alone are unlikely to be curative, although some success with antibiotic therapy alone has been reported in a small number of patients with abscesses &lt;3 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/17,30\">",
"     17,30",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Drainage'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The optimal duration of antibiotics is uncertain; three to six weeks of therapy following adequate drainage is likely appropriate [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/22,30\">",
"     22,30",
"    </a>",
"    ]. Followup imaging should be performed near the end of the planned course of antimicrobial therapy to ensure satisfactory response to therapy. Tuberculous abscesses are normally treated for six months.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psoas abscess can portend significant morbidity and mortality. In one series mortality due to primary and secondary abscess was 2.4 and 19 percent, respectively; in untreated cases mortality may approach 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/1\">",
"     1",
"    </a>",
"    ]. Risk factors for mortality include delayed or inadequate treatment, advanced age, the presence of bacteremia, and infection due to E. coli [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/5,30\">",
"     5,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Relapse can occur up to one year after initial presentation; this outcome has been reported in 15 to 36 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/5,26,40\">",
"     5,26,40",
"    </a>",
"    ]. Recurrence may be associated with inadequate drainage or inadequate antimicrobial therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/11\">",
"     11",
"    </a>",
"    ]. In addition, presence of hip flexion deformity at clinical presentation may not completely resolve as a result to fibrosis within the iliopsoas sheath [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A psoas (or iliopsoas) abscess is a collection of pus in the iliopsoas muscle compartment [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22839/abstract/1\">",
"       1",
"      </a>",
"      ]. It may arise via contiguous spread from adjacent structures (secondary abscess) or by the hematogenous route from a distant site (primary abscess). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Primary psoas abscesses are most frequently due to infection with a single organism. In regions where Mycobacterium tuberculosis is endemic, this is a frequent cause of psoas abscess. The most common bacterial cause is Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA). Secondary psoas abscess may be monomicrobial or polymicrobial and frequently consist of enteric organisms (both aerobic and anaerobic bacteria). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Signs and symptoms of psoas abscess include back or flank pain, fever, inguinal mass, limp, anorexia, and weight loss. Pain may localize to the back, flank, or lower abdomen, with or without radiation to the hip",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the posterior aspect of the thigh. Limitation of hip movement is common and patients frequently prefer to be in a position of less discomfort that includes hip flexion and lumbar lordosis. Pain is exacerbated when performing movements in which the psoas muscle is stretched or extended; the \"psoas sign\" is pain brought on by extension of the hip. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of a psoas abscess may be suspected on clinical grounds and confirmed on imaging studies. Computed tomography is the optimal radiographic modality to evaluate for psoas abscess. Blood samples and abscess material should be sent to the microbiology lab for Gram stain and bacterial culture. AFB smear and mycobacterial culture should also be performed in the setting of risk for tuberculosis. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Management of psoas abscess consists of drainage and prompt initiation of appropriate antibiotic therapy. We suggest initial management with percutaneous drainage (by ultrasound or CT guidance) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Following needle aspiration a pigtail catheter may be placed in situ to allow further drainage. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Drainage'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Empiric antibiotic therapy should include activity against S. aureus (including activity against MRSA in regions where prevalence is substantial) and enteric organisms (both aerobic and anaerobic enteric flora) (",
"      <a class=\"graphic graphic_table graphicRef64723 \" href=\"UTD.htm?6/51/6972\">",
"       table 1",
"      </a>",
"      ). Antimicrobial therapy should be tailored to culture and susceptibility results. Evidence of mycobacterial infection should prompt management as described in detail separately. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Antibiotics'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/1\">",
"      Mallick IH, Thoufeeq MH, Rajendran TP. Iliopsoas abscesses. Postgrad Med J 2004; 80:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/2\">",
"      M&uuml;ckley T, Sch&uuml;tz T, Kirschner M, et al. Psoas abscess: the spine as a primary source of infection. Spine (Phila Pa 1976) 2003; 28:E106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/3\">",
"      Ricci MA, Rose FB, Meyer KK. Pyogenic psoas abscess: worldwide variations in etiology. World J Surg 1986; 10:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/4\">",
"      Santaella RO, Fishman EK, Lipsett PA. Primary vs secondary iliopsoas abscess. Presentation, microbiology, and treatment. Arch Surg 1995; 130:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/5\">",
"      Navarro L&oacute;pez V, Ramos JM, Meseguer V, et al. Microbiology and outcome of iliopsoas abscess in 124 patients. Medicine (Baltimore) 2009; 88:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/6\">",
"      Gruenwald I, Abrahamson J, Cohen O. Psoas abscess: case report and review of the literature. J Urol 1992; 147:1624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/7\">",
"      Buttaro M, Gonz&aacute;lez Della Valle A, Piccaluga F. Psoas abscess associated with infected total hip arthroplasty. J Arthroplasty 2002; 17:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/8\">",
"      Lee BB, Ngan Kee WD, Griffith JF. Vertebral osteomyelitis and psoas abscess occurring after obstetric epidural anesthesia. Reg Anesth Pain Med 2002; 27:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/9\">",
"      Dolfin D, Barkin J, Arenson AM, Herschorn S. Psoas abscess after operation on lumbar spine. Urology 1983; 21:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/10\">",
"      Lin SS, Vaccaro AR, Reisch S, et al. Low-velocity gunshot wounds to the spine with an associated transperitoneal injury. J Spinal Disord 1995; 8:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/11\">",
"      Lin MF, Lau YJ, Hu BS, et al. Pyogenic psoas abscess: analysis of 27 cases. J Microbiol Immunol Infect 1999; 32:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/12\">",
"      Alpantaki K, Papoutsidakis A, Katonis P, Hadjipavlou A. Vertebral osteomyelitis, epidural and psoas abscess after epidural catheter use. Acta Orthop Belg 2007; 73:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/13\">",
"      Maron R, Levine D, Dobbs TE, Geisler WM. Two cases of pott disease associated with bilateral psoas abscesses: case report. Spine (Phila Pa 1976) 2006; 31:E561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/14\">",
"      Dauchy FA, Dupon M, Dutronc H, et al. Association between psoas abscess and prosthetic hip infection: a case-control study. Acta Orthop 2009; 80:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/15\">",
"      Gordin F, Stamler C, Mills J. Pyogenic psoas abscesses: noninvasive diagnostic techniques and review of the literature. Rev Infect Dis 1983; 5:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/16\">",
"      Ogihara M, Masaki T, Watanabe T, et al. Psoas abscess complicating Crohn's disease: report of a case. Surg Today 2000; 30:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/17\">",
"      Yacoub WN, Sohn HJ, Chan S, et al. Psoas abscess rarely requires surgical intervention. Am J Surg 2008; 196:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/18\">",
"      Hsu RB, Lin FY. Psoas abscess in patients with an infected aortic aneurysm. J Vasc Surg 2007; 46:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/19\">",
"      Inufusa A, Mikawa Y, Morita I, Fujiwara T. Ruptured abdominal aortic aneurysm associated with a psoas abscess. Arch Orthop Trauma Surg 2002; 122:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/20\">",
"      Sharif MA, Lee B, Lau LL, et al. Prosthetic stent graft infection after endovascular abdominal aortic aneurysm repair. J Vasc Surg 2007; 46:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/21\">",
"      Klonaris C, Vourliotakis G, Katsargyris A, et al. Primary aortoduodenal fistula without abdominal aortic aneurysm in association with psoas abscess. Ann Vasc Surg 2006; 20:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/22\">",
"      Lee YT, Lee CM, Su SC, et al. Psoas abscess: a 10 year review. J Microbiol Immunol Infect 1999; 32:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/23\">",
"      Alan C, Ataus S, Tun&ccedil; B. Xanthogranulamatous pyelonephritis with psoas abscess: 2 cases and review of the literature. Int Urol Nephrol 2004; 36:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/24\">",
"      Flavin NE, Gomez M. Fever, pain, and a limp: a case of a psoas and spinal epidural abscess caused by methicillin-resistant Staphylococcus aureus in a diabetic patient. J Natl Med Assoc 2009; 101:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/25\">",
"      De U, Pal DK. Seventy cases of non-tubercular psoas abscess at a rural referral centre in South Bengal. Trop Doct 2006; 36:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/26\">",
"      Chang CM, Ko WC, Lee HC, et al. Klebsiella pneumoniae psoas abscess: predominance in diabetic patients and grave prognosis in gas-forming cases. J Microbiol Immunol Infect 2001; 34:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/27\">",
"      Giladi M, Sada MJ, Spotkov J, Bayer AS. Pneumococcal psoas abscess: report of a case and review of the world literature. Isr J Med Sci 1996; 32:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/28\">",
"      Dubois D, Robin F, Bouvier D, et al. Streptobacillus moniliformis as the causative agent in spondylodiscitis and psoas abscess after rooster scratches. J Clin Microbiol 2008; 46:2820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/29\">",
"      Heyd J, Meallem R, Schlesinger Y, et al. Clinical characteristics of patients with psoas abscess due to non-typhi Salmonella. Eur J Clin Microbiol Infect Dis 2003; 22:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/30\">",
"      Huang JJ, Ruaan MK, Lan RR, Wang MC. Acute pyogenic iliopsoas abscess in Taiwan: clinical features, diagnosis, treatments and outcome. J Infect 2000; 40:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/31\">",
"      Bresee JS, Edwards MS. Psoas abscess in children. Pediatr Infect Dis J 1990; 9:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/32\">",
"      Stefanich RJ, Moskowitz A. Hip flexion deformity secondary to acute pyogenic psoas abscess. Orthop Rev 1987; 16:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/33\">",
"      Fish DE, Middleton K, Gluzman A. Atypical presentation of osteomyelitis, discitis, epidural, and iliopsoas abscess in diffuse idiopathic skeletal hyperostosis (DISH) syndrome. Am J Phys Med Rehabil 2008; 87:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/34\">",
"      Arai Y, Kawakami T, Soga H, Okada Y. Psoas abscess associated with iliac vein thrombosis and piriformis and gluteal abscesses. Int J Urol 1999; 6:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/35\">",
"      Kao PF, Tzen KY, Tsui KH, et al. The specific gallium-67 scan uptake pattern in psoas abscesses. Eur J Nucl Med 1998; 25:1442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/36\">",
"      Zissin R, Gayer G, Kots E, et al. Iliopsoas abscess: a report of 24 patients diagnosed by CT. Abdom Imaging 2001; 26:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/37\">",
"      Lee JK, Glazer HS. Psoas muscle disorders: MR imaging. Radiology 1986; 160:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/38\">",
"      Kishi Y, Kajiwara S, Seta S, et al. Retroperitoneal schwannoma misdiagnosed as a psoas abscess: report of a case. Surg Today 2002; 32:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/39\">",
"      Atkin G, Qurashi K, Isla A. Laparoscopic drainage of bilateral tuberculous psoas abscesses. Surg Laparosc Endosc Percutan Tech 2005; 15:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22839/abstract/40\">",
"      Sherman SJ, Stern J, Neufeld P. Recurrent psoas abscess. Postgrad Med 1987; 81:96, 99.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7652 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.195.65.244-FC54B750F8-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22839=[""].join("\n");
var outline_f22_19_22839=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Primary abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Secondary abscess",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Adjacent structures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Signs and symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Culture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Histopathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Drainage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7652\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7652|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/51/6972\" title=\"table 1\">",
"      Empiric treatment psoas abscess",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/50/12071?source=related_link\">",
"      Approach to imaging modalities in the setting of suspected osteomyelitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16489?source=related_link\">",
"      Clinical manifestations and diagnosis of nocardiosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=related_link\">",
"      Diagnosis of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/46/42726?source=related_link\">",
"      Hematogenous osteomyelitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/31/29176?source=related_link\">",
"      Invasive liver abscess syndrome caused by Klebsiella pneumoniae",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/49/37656?source=related_link\">",
"      Skeletal tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=related_link\">",
"      Treatment of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=related_link\">",
"      Treatment of pulmonary tuberculosis in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/28/22985?source=related_link\">",
"      Vertebral osteomyelitis and discitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/26/16804?source=related_link\">",
"      Xanthogranulomatous pyelonephritis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_19_22840="Normal adult wrist AP xray";
var content_f22_19_22840=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F70211%7ERHEUM%2F78664%7EEM%2F58484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F70211%7ERHEUM%2F78664%7EEM%2F58484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Carpal bones",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 344px; height: 612px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This anterior posterior radiograph of the wrist shows the locations and names of the eight bones of the capus. The proximal row (from radial to ulnar) is composed of the scaphoid (also known as the navicular), lunate, triquetrum, and pisiform. In the distal row are the trapezium, trapezoid, capitate, and hamate.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin E. Burroughs, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lateral view of wrist",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 346px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This lateral radiograph of a normal adult wrist shows the outlines of scaphoid, lunate, and capitate bones.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin E Burroughs, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scaphoid view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 332px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This posterior anterior (PA) radiograph of the wrist taken with ulnar deviation of the hand serves to isolate the scaphoid (arrow) from overlaping shadows.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin E. Burroughs, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22840=[""].join("\n");
var outline_f22_19_22840=null;
var title_f22_19_22841="Treatment of rheumatoid vasculitis";
var content_f22_19_22841=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of rheumatoid vasculitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/19/22841/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/19/22841/contributors\">",
"     Patrick Whelan, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/19/22841/contributors\">",
"     John H Stone, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/19/22841/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/19/22841/contributors\">",
"     Gene G Hunder, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/19/22841/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/19/22841/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/19/22841/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term &ldquo;rheumatoid vasculitis&rdquo; (RV) refers specifically to a protean, inflammatory process in patients with rheumatoid arthritis (RA) that is centered on the blood vessel wall itself. Although RV has a range of disease severity, the condition may be associated with substantial potential morbidity, may require intensive immunosuppressive therapy, and may lead to a significantly higher mortality than does RA itself. The disease typically occurs in patients with longstanding, erosive RA. RV may affect a wide range of blood vessel types, from medium-sized muscular arteries to somewhat smaller arterioles or to post-capillary venules. Within a given patient, clinical features of both medium- and small-vessel disease may be found. RV may lead to necrosis, to blood vessel occlusion, and to tissue ischemia in a manner that resembles other forms of systemic vasculitis.",
"   </p>",
"   <p>",
"    In its tendency to affect medium-sized arteries and to involve the skin, peripheral nerves, eyes, heart, muscles, and other organs, RV often has a clinical appearance similar to polyarteritis nodosa. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/26/9641?source=see_link\">",
"     \"Clinical manifestations and diagnosis of polyarteritis nodosa\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment of RV is the focus of this topic review. Many of the standard treatment practices for RV have been adapted from those for other forms of systemic vasculitis, particularly granulomatosis with polyangiitis (Wegener&rsquo;s). The pathogenesis, clinical manifestations, and diagnosis of RV are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/26/42407?source=see_link\">",
"     \"Epidemiology and pathogenesis of rheumatoid vasculitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20697?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rheumatoid vasculitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     THE CLINICAL CONTEXT OF RV",
"    </span>",
"    &nbsp;&mdash;&nbsp;In considering treatment approaches for the patient with rheumatoid vasculitis (RV), an understanding of the clinical context in which this extraarticular manifestation of RA occurs is essential. The typical patient with RV has suffered from RA for at least a decade before systemic vasculitis becomes apparent. At the time of RV onset, unfortunately, patients who have already incurred considerable morbidity from RA and its therapies require intensive, potentially toxic treatments more than ever.",
"   </p>",
"   <p>",
"    The incidence of RV appears to be decreasing since the 1980s, suggesting that more aggressive treatment of RA may help to prevent the development of RV [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/26/42407?source=see_link&amp;anchor=H180544048#H180544048\">",
"     \"Epidemiology and pathogenesis of rheumatoid vasculitis\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment considerations are often complicated by comorbidities that RV patients have sustained through the years: cytopenias, renal dysfunction, hepatic damage, gastrointestinal ulceration, and the manifold complications of glucocorticoids, including hypertension, glucose intolerance, skin fragility, and others. The art (and the success) of treating RV lies in balancing the need for stringent therapies with the patient&rsquo;s potentially increased susceptibility to treatment complications.",
"   </p>",
"   <p>",
"    The type, distribution, and severity of organ damage resulting from RV are used to determine appropriate treatment. Isolated cutaneous involvement generally has a good prognosis and often does not require immunosuppressive drug therapy; however, some forms of cutaneous vasculitis, particularly vasculitis-induced ulcers, have often required",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    in order to induce disease control. In contrast, systemic RV with involvement of internal organs, muscle, or peripheral nerves has a poorer prognosis and warrants immunosuppressive treatment, typically with initially high doses of glucocorticoids in combination with cyclophosphamide.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     Rituximab",
"    </a>",
"    may be an alternative to cyclophosphamide in some patients given case reports of benefit in patients with RV and given its favorable comparison with cyclophosphamide in a randomized trial (the Rituximab for ANCA-associated vasculitis [RAVE] trial) involving patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    RV is also mimicked by a number of infections, including both viral (human immunodeficiency virus, hepatitis, herpes zoster) and bacterial (tuberculosis, endocarditis) etiologies that must be excluded before initiating immunosuppressive therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20697?source=see_link&amp;anchor=H23#H23\">",
"     \"Clinical manifestations and diagnosis of rheumatoid vasculitis\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Early comprehensive care and regular follow-up, particularly among the subset of patients with RA who are anti-citrullinated peptide antibody (ACPA) positive and who have extraarticular manifestations, may be critical to the prevention of RV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CUTANEOUS VASCULITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted, isolated nailfold infarctions have a good prognosis while leg ulcerations due to RV may require treatment similar to that used for systemic involvement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Isolated nailfold infarctions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolated nailfold infarctions (",
"    <a class=\"graphic graphic_picture graphicRef74000 \" href=\"UTD.htm?21/17/21776\">",
"     picture 1",
"    </a>",
"    ), due to a low-grade small-vessel vasculitis similar to that which causes rheumatoid nodules [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/6,7\">",
"     6,7",
"    </a>",
"    ], can be treated symptomatically or can simply be observed since there is a low risk for progression to systemic RV [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/8\">",
"     8",
"    </a>",
"    ]. Long-term follow-up in 30 patients with nailfold vasculitis validated this approach [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/9\">",
"     9",
"    </a>",
"    ]. Although patients with isolated nailfold vasculitis are at increased risk for other types of extraarticular disease, no particular therapy is required for these lesions. They do not herald the imminent arrival of &ldquo;full-blown&rdquo; RV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Leg ulceration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histologic evidence of cutaneous vasculitis is common in skin biopsies obtained at the time of skin grafting for patients who have RA and non-healing skin ulcers. This was illustrated in a study of 20 Swedish patients with RA; 11 had cutaneous vasculitis present in a sample of skin from the ulcer margin or of skin distant from the ulcerative lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Enlarging cutaneous ulcers may be the earliest clinical evidence of RV. Other clinical entities, however, may also cause leg ulcers in RV. Pyoderma gangrenosum occurs occasionally in RA but is significantly less common than ulcers due to RV. Indeed, because of the absence of a diagnostic histopathology of pyoderma gangrenosum and because of the frequency with which biopsies in RV are non-diagnostic, many cases of pyoderma gangrenosum associated with RA in the past were probably a manifestation of RV. Another factor that may contribute to the development of leg ulcers in RA is the combination of venous stasis disease and chronic glucocorticoid use, the latter of which leads to increased skin fragility and to a tendency to ulcerations with minor trauma. In short, the development of leg ulcers should trigger a thorough evaluation for the possibility of RV including, if appropriate, a skin biopsy. Not all skin ulcerations in RA, however, represent RV.",
"   </p>",
"   <p>",
"    In the absence of systemic RV, the initial treatment of leg ulcerations is similar to that for skin ulcers due to venous stasis. This is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32410?source=see_link\">",
"     \"Medical management of lower extremity chronic venous disease\"",
"    </a>",
"    .) The following is a brief summary of topical therapies employed for leg ulcers:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If eschar is present, wet-to-moist saline dressings may be used to debride the ulcer to a base of granulation tissue.",
"     </li>",
"     <li>",
"      If the arterial circulation is adequate, compression bandages or stockings may help reduce swelling if there is concomitant venous stasis.",
"     </li>",
"     <li>",
"      Occlusive hydrocolloid (or hydrogel) dressings or, for patients with very exudative ulcers, calcium alginate-containing dressings are suggested.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Antibiotic-containing ointments or creams are not recommended. Topical glucocorticoids may be used, but their efficacy for skin ulcers due to RV is uncertain.",
"   </p>",
"   <p>",
"    Ulcers that do not respond to conservative measures may signal the presence of underlying RV. For patients who have systemic RV and skin ulcerations, immunosuppressive therapy, as well as local skin care, is essential for healing. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Systemic vasculitis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The diagnosis of RV should be confirmed by biopsy or by angiography prior to initiating immunosuppressive therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20697?source=see_link&amp;anchor=H20#H20\">",
"     \"Clinical manifestations and diagnosis of rheumatoid vasculitis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although there are similarities between the treatments for RV and other forms of vasculitis, RV is unique in that intensification of primary therapy for the patient&rsquo;s RA (eg, biologic therapies) may prove more effective in RV than in other vasculitides [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients whose skin ulcers do not respond to topical therapy and systemic immunosuppression are candidates for skin grafting. Pinch skin grafts appear to be similarly effective in healing ulcers in RA patients with or without biopsy evidence of cutaneous vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Topically applied growth factors represent an investigational, approach to the treatment of RV-associated skin ulcers. As an example, an uncontrolled study of four patients with RA and recalcitrant vasculitic leg ulcers reported rapid healing with topical application of recombinant nerve growth factor [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/12\">",
"     12",
"    </a>",
"    ]. This agent is not available for clinical use.",
"   </p>",
"   <p>",
"    Thrombosis can be a component of vascular compromise in RV. One report described a patient with coincident",
"    <span class=\"nowrap\">",
"     anti-phosphatidylserine/prothrombin",
"    </span>",
"    complex antibodies, who initially tested positive for lupus anticoagulant [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/13\">",
"     13",
"    </a>",
"    ]. She was treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/57/20375?source=see_link\">",
"     argatroban",
"    </a>",
"    , a synthetic thrombin inhibitor, with complete resolution of skin ulceration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SYSTEMIC VASCULITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biopsy-proven systemic RV, even disease seemingly limited to one organ alone (eg, ulcerative disease of the skin, ocular disease, or vasculitic neuropathy), requires aggressive therapy, typically with high-dose glucocorticoids plus either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    . However, treatment decisions must be tailored to the clinical circumstances of each individual patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Initial therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Information specifically related to the treatment of systemic RV, contained in individual case reports or case series, suggests that most patients should be treated with a regimen similar to that used in forms of primary systemic vasculitis such as granulomatosis with polyangiitis (Wegener&rsquo;s) and polyarteritis nodosa. In general, this treatment regimen has consisted of the combination of high doses of glucocorticoids and a cytotoxic agent (usually",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/14-18\">",
"     14-18",
"    </a>",
"    ]. In addition, treatment regimens using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    rather than cyclophosphamide have also been employed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/32/34314?source=see_link\">",
"     \"Initial immunosuppressive therapy in granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28119?source=see_link\">",
"     \"Treatment and prognosis of polyarteritis nodosa\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The goal of treatment of systemic RV is to achieve a remission characterized by an absence of active vascular inflammation. General measures of disease activity such as acute phase reactants (eg, erythrocyte sedimentation rate [ESR] or C-reactive protein [CRP]), laboratory measures of specific organ involvement (eg, serum creatinine, urinary sediment), and clinical observation are used to monitor the response to treatment. Although essentially all patients with RV have high titers of rheumatoid factor (RF) and although many have low serum complement levels, these measures are not reliable measures of disease activity (ie, treatment decisions should not be predicated upon changes in these potential biomarkers).",
"   </p>",
"   <p>",
"    As with other forms of systemic vasculitis, active disease must be distinguished from damage. &ldquo;Damage&rdquo; is defined as injuries to a given organ that are likely permanent, which have occurred as a result of the underlying disease process and which will not be reversible with immunosuppressive therapy. Common forms of damage in RV include the sequelae of peripheral nerve infarctions (eg, foot- or wrist-drop), scleral thinning caused by scleritis, and cutaneous scarring (",
"    <a class=\"graphic graphic_picture graphicRef82099 \" href=\"UTD.htm?43/35/44592\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with severe RV should receive one to three days of pulse",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    (generally between 100 mg and 1 gram daily, administered intravenously). Patients who are judged to be on the sicker end of the disease spectrum should receive 1 gram daily for three days. Pulse glucocorticoid therapy should then be followed by 1",
"    <span class=\"nowrap\">",
"     mg/kg/day",
"    </span>",
"    of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    , up to 80",
"    <span class=\"nowrap\">",
"     mg/day.",
"    </span>",
"    In many patients, these high initial doses of glucocorticoid therapy need to be modified because of existing glucocorticoid-related morbidity. The goal of the prednisone taper should be to lower patients&rsquo; prednisone doses to 20",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    by two months of treatment and then to 5",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    or less (eg, the minimum dose required to manage their RA) by six months of therapy.",
"   </p>",
"   <p>",
"    The use of glucocorticoids in RV has not been evaluated in placebo-controlled trials. Such trials are unlikely to be performed, due to the general acceptance of the role of glucocorticoids in achieving initial control of systemic vasculitis. In selected patients with RV, high-dose glucocorticoids may be sufficient to induce disease remission. Selection of such patients on the basis of their a priori clinical characteristics, however, is challenging. A sizeable subset of patients with RV requires",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    in addition to high-dose glucocorticoids in order to achieve disease remission.",
"   </p>",
"   <p>",
"    A variety of regimens for glucocorticoid administration have been employed. Patients with aggressive disease are usually begun on pulse",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    , followed by daily oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H178919555\">",
"    <span class=\"h3\">",
"     Rituximab",
"    </span>",
"    &nbsp;&mdash;&nbsp;We prefer to use the combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    (375",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    weekly times four doses), a humanized anti-CD20 monoclonal antibody, plus high-dose glucocorticoids (see",
"    <a class=\"local\" href=\"#H8\">",
"     'Glucocorticoids'",
"    </a>",
"    above) as the first-line treatment in nearly all patients with severe RV because rituximab may be safer than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    in this population of patients with severe disease who have typically received substantial courses of immunosuppressive therapies even before the onset of RV. We hold cyclophosphamide in reserve for patients who appear to be failing this approach. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/32/34314?source=see_link&amp;anchor=H16198972#H16198972\">",
"     \"Initial immunosuppressive therapy in granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\", section on 'Rituximab'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     Rituximab",
"    </a>",
"    was developed as a treatment for B-cell lymphomas and is used for the treatment of RA; it may also be effective for the treatment of RV. No head-to-head randomized trials have directly compared",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    and rituximab in patients with RV, but findings in a small cohort of patients with RA treated with rituximab for systemic RV suggested that it may be safe and effective therapy for induction, salvage (in patients previously treated with cyclophosphamide), and, possibly, maintenance therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/19\">",
"     19",
"    </a>",
"    ]. In addition, small case series and a larger clinical trial (known as the RAVE trial) have demonstrated the potential benefits of rituximab as a therapy for systemic vasculitis unrelated to RA [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/3,20,21\">",
"     3,20,21",
"    </a>",
"    ]. In the RAVE trial, rituximab had comparable efficacy to cyclophosphamide in ANCA-associated disorders such as granulomatosis with polyangiitis (Wegener&rsquo;s) and microscopic polyangiitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The safety and efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    for treatment of RV were addressed in an analysis of data from a prospective cohort study investigating the long-term safety and efficacy of rituximab for treating RA and other autoimmune diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/19\">",
"     19",
"    </a>",
"    ]. This registry, involving 88 French centers and 1994 patients with RA treated with rituximab, included 10 women and seven men with RV who were treated with rituximab (given either in two or four infusions) for active systemic RV. The vasculitis had been present for a mean duration of 30 months; most of the patients had severe skin involvement and mononeuritis multiplex, with pleural effusions in three and pericarditis in one. Four of the patients (24 percent) had received",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    previously for their vasculitis and were being treated for relapse. After six months, 12 patients (71 percent) receiving rituximab had achieved complete remission of the vasculitis, four patients responded partially, and one patient died from uncontrolled vasculitis. Six patients (35 percent) were retreated at six months. At one year after initiation of therapy, 14 patients (82 percent) were in sustained complete remission, including all those who were retreated, and mean",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    doses had been reduced from 19.2 to 9.7 mg daily. The severe infection rate was 6.4 per 100 patient-years. Compared with historical data, rituximab appeared to be associated with lower mortality compared with the use of cyclophosphamide as primary therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H178919562\">",
"    <span class=\"h3\">",
"     Cyclophosphamide",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with severe RV who appear to be failing the combination of high-dose glucocorticoids and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    , we treat with daily",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    , up to 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day, assuming normal renal function. Dose adjustments should be made for patients with renal dysfunction. At the initiation of daily cyclophosphamide, the use of pulse",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    (eg, up to 1",
"    <span class=\"nowrap\">",
"     gram/day",
"    </span>",
"    for one to three days) may also be appropriate, based upon the acuity and severity of the patient's illness. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Glucocorticoids'",
"    </a>",
"    above.) Decisions about when to initiate cyclophosphamide after a course of rituximab has been initiated must be individualized according to the patient, but RV patients treated with the combination of high-dose glucocorticoids and rituximab should begin to show signs of improvement (albeit not complete remission) within three weeks of starting treatment (ie, by the time of the fourth rituximab infusion). In patients in whom no improvement is evident at that point and in whom ongoing activity of disease attributable to vasculitis persists, it is reasonable to consider cyclophosphamide.",
"   </p>",
"   <p>",
"    Use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    , although not studied in controlled trials in RV, appears to alter the natural history of RV in many patients. A wealth of clinical experience (pertaining to systemic vasculitis in general, as well as to RV) suggests that, for a significant percentage of RV cases, the inflammatory process may be only partially checked by high doses of glucocorticoids. In such cases, disease control and remission induction are dependent upon cyclophosphamide.",
"   </p>",
"   <p>",
"    Both daily oral and intermittent intravenous (IV)",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    regimens have been studied in systemic vasculitis. No compelling studies permit a strong, evidence-based preference of one route of administration over the other. Nevertheless, the usual approach to the treatment of systemic vasculitis in diseases as diverse as granulomatosis with polyangiitis (Wegener&rsquo;s) and polyarteritis nodosa has been to employ daily cyclophosphamide therapy. Daily oral cyclophosphamide was used in a small series of five patients with RV, all of whom achieved initial disease remission [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/32/34314?source=see_link\">",
"     \"Initial immunosuppressive therapy in granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28119?source=see_link\">",
"     \"Treatment and prognosis of polyarteritis nodosa\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Daily oral therapy also permits close titration of the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    dose, based principally upon the white blood cell count. Whereas an IV bolus of cyclophosphamide cannot be withdrawn once administered, daily cyclophosphamide doses may be altered more readily in the event of an adverse effect of therapy.",
"   </p>",
"   <p>",
"    There are no trials in patients with RV that directly compared daily oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    with intermittent (or pulse) IV cyclophosphamide. The largest study of intermittent IV cyclophosphamide was a retrospective, unblinded comparison of the outcomes of 21 patients with RV, who received a combination of IV cyclophosphamide plus IV",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    , with those of 24 patients who received a variety of other therapies (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    , D-penicillamine,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/52/35654?source=see_link\">",
"     chlorambucil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The IV regimen consisted of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    1500 mg and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    500 mg the first week, followed by methylprednisolone 1000 mg and cyclophosphamide (15",
"    <span class=\"nowrap\">",
"     mg/kg,",
"    </span>",
"    maximum dose 1000 mg) at weeks one, four, and seven. Maintenance therapy consisted of either daily oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    (2",
"    <span class=\"nowrap\">",
"     mg/kg/day)",
"    </span>",
"    or oral cyclophosphamide (1.5",
"    <span class=\"nowrap\">",
"     mg/kg/day).",
"    </span>",
"    Despite the fact that the IV cyclophosphamide group had more severe initial disease, the proportion of patients who had skin healing or significant improvement in skin lesions or in other manifestations of RV within four months of beginning treatment was numerically greater with IV cyclophosphamide, was associated with fewer treatment complications, and had a smaller number of deaths.",
"   </p>",
"   <p>",
"    Whenever",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    and high-dose glucocorticoids are employed together, prophylaxis with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    (one single-strength tablet daily) is prudent to reduce the risk of Pneumocystis pneumonia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Alternatives to rituximab and cyclophosphamide",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    is contraindicated or if there is evidence of continued disease activity despite high-dose glucocorticoid therapy plus rituximab",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cyclophosphamide, alternative approaches to therapy must be considered. We use",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    as the next immunosuppressive agent, while continuing glucocorticoids in such patients. When confronted with refractory vasculitis, however, the clinician must re-examine the question of how much of the patient&rsquo;s ongoing clinical manifestations relate to active vasculitis as opposed to damage, to a comorbid condition, or to an adverse effect of therapy.",
"   </p>",
"   <p>",
"    Failure of the combination of high-dose glucocorticoids and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    could be followed by the addition of a TNF inhibitor. In the rare case that RV appears to progress despite these measures,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/52/35654?source=see_link\">",
"     chlorambucil",
"    </a>",
"    can be used as a last resort.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     Methotrexate",
"    </a>",
"    is of uncertain efficacy in patients with RV. Some patients have developed RV while on maintenance methotrexate therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/23\">",
"     23",
"    </a>",
"    ]. In such patients, we suggest discontinuing methotrexate while other immunosuppressive therapy is administered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H180542524\">",
"    <span class=\"h4\">",
"     Azathioprine",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients who need an alternative to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    for initial therapy of systemic RV, the combination of high-dose glucocorticoids plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    is a reasonable option. An initial dose of azathioprine of 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    daily is typically used, although a higher dose (up to 2.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    daily without exceeding a total maximal dose of 250 mg daily in adults) may be used in the absence of contraindications and in the presence of severe disease manifestations. Before starting azathioprine, patients should undergo testing for the presence of thiopurine methyltransferase alleles; this enzyme is required in order to metabolize azathioprine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/63/10232?source=see_link&amp;anchor=H4#H4\">",
"     \"Pharmacology and side effects of azathioprine when used in rheumatic diseases\", section on 'Pharmacogenetics and TPMT testing'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/63/10232?source=see_link\">",
"     \"Pharmacology and side effects of azathioprine when used in rheumatic diseases\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one uncontrolled study, nine patients with systemic RV improved with a combination of oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    (60",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    (2",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/22\">",
"     22",
"    </a>",
"    ]. In contrast, a trial that randomly assigned 15 patients to receive either azathioprine or placebo in addition to glucocorticoids noted no significant difference in outcomes between the two groups [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H180542630\">",
"    <span class=\"h4\">",
"     Other agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evidence for the usefulness of agents other than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    for systemic RV is limited to small clinical trials, to uncontrolled series,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    to individual case reports.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Tumor necrosis factor (TNF) inhibitors",
"      </strong>",
"      &mdash; No prospective trials have been conducted with TNF blockers in RV patients. Given the effectiveness of TNF inhibitors in treating the synovitis of RA, however, the use of these agents in RV is intriguing. Of note, however, a growing experience with randomized trials of TNF inhibitors in other forms of vasculitis (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/31/28151?source=see_link\">",
"       etanercept",
"      </a>",
"      in granulomatosis with polyangiitis [Wegener&rsquo;s] [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/25\">",
"       25",
"      </a>",
"      ] and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"       infliximab",
"      </a>",
"      in giant cell arteritis [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/26\">",
"       26",
"      </a>",
"      ]) has documented the failure of targeted TNF inhibition in these diseases.",
"      <br/>",
"      <br/>",
"      One retrospective study identified nine patients (five men and four women) in France previously treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      who were either uncontrolled or relapsed for RV [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/19\">",
"       19",
"      </a>",
"      ]. Virtually all had nerve or skin involvement. Seven were treated with infliximab, and two were treated with etanercept, for a mean 28 weeks. Four of the infliximab patients and one of the etanercept patients achieved complete remission of their vasculitis. However, one patient died, and two were withdrawn from anti-TNF therapy because of infection.",
"      <br/>",
"      <br/>",
"      Case reports and small case series further document the limited experience with TNF inhibitors in RV. Two RV patients (a 65-year-old woman with cutaneous vasculitis and a 37-year-old woman with mononeuritis multiplex), along with seven granulomatosis with polyangiitis (Wegener&rsquo;s) patients, experienced complete or partial remission with treatment regimens that included infliximab (and other medications) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/27\">",
"       27",
"      </a>",
"      ]. A second group of three patients with RV also had good outcomes following infliximab treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/28\">",
"       28",
"      </a>",
"      ]. Complete recovery was described in a 48-year-old man with recurrent pericardial effusions, leukopenia, and kidney and liver involvement, who had failed previous therapy with cyclophosphamide, pulse glucocorticoids, and plasmapheresis. Two other patients, a man and woman in their 60s, had non-healing skin ulcers refractory to cyclophosphamide that responded completely to infliximab. All three were treated with 3",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      infliximab, given every eight weeks after stabilization of disease. Other individual case reports with good outcomes have been published [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/29-31\">",
"       29-31",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Despite the promising uncontrolled experiences with infliximab, some concern has been raised that treatment with TNF antagonists may, in some instances, actually promote the development of vasculitis. One report described two men with nodular, erosive, seropositive RA and RV whose arthritis was treated successfully with etanercept. However, one developed splinter hemorrhages and cutaneous vasculitis. The other developed cavitating pulmonary lesions and biopsy-demonstrated necrotizing vasculitis at the site of old asymptomatic pulmonary nodules [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/32\">",
"       32",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Three additional cases of cutaneous vasculitis in adult RA patients treated with etanercept have been reported, all having experienced significant improvement in their arthritis prior to onset of the rash [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]. Similarly, purpura akin to that seen in Henoch-Sch&ouml;nlein has been described in a pediatric RV patient treated with etanercept, with resolution after withdrawal and with recurrence on reintroduction [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/35\">",
"       35",
"      </a>",
"      ]. Similar cases have been reported in patients treated with infliximab [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/36\">",
"       36",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      TNF inhibitors can be associated with a cutaneous vasculitis that is consistent with hypersensitivity. A review of all cases registered in the Adverse Events Reporting System of the Food and Drug Administration between 1998 and 2002 described 35 cases, 20 following etanercept and 15 following infliximab [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/37\">",
"       37",
"      </a>",
"      ]. Of these cases, 49 percent were proven by biopsy to be vasculitis, generally involving only the skin. The other cases were diagnosed clinically. Twenty-two of the 35 patients (63 percent) had complete resolution or substantial improvement of their rashes after stopping anti-TNF therapy. Six patients had recurrence of the lesions after restarting a TNF blocker.",
"      <br/>",
"      <br/>",
"      Although anti-TNF therapies have been linked to the development of cutaneous vasculitis in some patients with RA, the types of vasculitis reported with TNF inhibitors are generally mild, resemble a hypersensitivity vasculitis, and usually resolve with discontinuation of the drug. There is no indication that the use of TNF inhibitors predisposes patients to the development of RV.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/14/18662?source=see_link\">",
"       Abatacept",
"      </a>",
"      <strong>",
"      </strong>",
"      &mdash; Abatacept is another agent used to treat RA that is refractory to disease-modifying antirheumatic drugs (DMARDs) and anti-TNF agents. There is no published experience with the use of abatacept as a treatment for RV.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/52/35654?source=see_link\">",
"       Chlorambucil",
"      </a>",
"      <strong>",
"      </strong>",
"      &mdash; Chlorambucil, an alkylating agent of similar potency to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      , was once used to treat patients with RA and juvenile idiopathic arthritis (JIA) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/38\">",
"       38",
"      </a>",
"      ]. However, chlorambucil treatment never gained widespread acceptance as an RA therapy, largely because of its adverse effects profile, particularly bone marrow toxicity (thrombocytopenia) and a propensity to cause hematopoietic malignancies. For patients with severe RV who cannot take cyclophosphamide (usually because of cyclophosphamide-induced cystitis), chlorambucil could be considered. However, chlorambucil is used only very rarely for RA or RV because of therapeutic advances that have made better alternatives available.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Maintenance therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have had remission from RV induced by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    should be considered for maintenance therapy with this medication. For patients with severe RV, however, we generally retreat patients at least once following the return of B cells to measurable concentrations, which typically occurs after 6 to 12 months. Alternative approaches include treating patients with rituximab every six months regardless of B cell concentrations or waiting until the return of active disease before reinstituting treatment with rituximab. No consensus has emerged regarding the need for or the timing of retreatment, and these decisions must be determined in practice on a case-by-case basis.",
"   </p>",
"   <p>",
"    If",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    is used to induce remission, the usual practice has been to induce remission with cyclophosphamide (typically after three to six months) and then to switch to a less toxic drug, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    (administered orally at a dose of 1.5 to 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    daily), to maintain the remission. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/23/6521?source=see_link\">",
"     \"Maintenance immunosuppressive therapy in granulomatosis with polyangiitis (Wegener&rsquo;s) and microscopic polyangiitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Relapse",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of relapse is variable and may be determined, in part, by the intensity and duration of initial therapy. In one study of 32 patients with RV and peripheral neuropathy, 53 percent survived disease-free, 25 percent suffered a relapse, and 22 percent failed to achieve remission over a mean follow-up of 7.4 years [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/39\">",
"     39",
"    </a>",
"    ]. Of the eight patients suffering relapse, only three recovered completely following retreatment. Major recurrence is generally treated with another course of induction therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Adjunctive care",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Preventing side effects of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the toxicities of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    and glucocorticoids when used in combination, prophylactic therapy should be provided:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Preventing Pneumocystis pneumonia (eg, single-strength",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      daily, or double-strength trimethoprim-sulfamethoxazole three times a week)",
"     </li>",
"     <li>",
"      Avoiding",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      -induced amenorrhea in women of child-bearing potential (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"       leuprolide",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Preventing hemorrhagic cystitis and bladder cancer (eg, hydration and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/0/41989?source=see_link\">",
"       mesna",
"      </a>",
"      ). These interventions are discussed in more detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16008?source=see_link\">",
"       \"General principles of the use of cyclophosphamide in rheumatic and renal disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25098?source=see_link&amp;anchor=H12#H12\">",
"       \"General toxicity of cyclophosphamide and chlorambucil in inflammatory diseases\", section on 'Prevention of gonadal toxicity'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25098?source=see_link&amp;anchor=H16#H16\">",
"       \"General toxicity of cyclophosphamide and chlorambucil in inflammatory diseases\", section on 'Prevention of bladder toxicity'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Preventing osteoporosis. Measurement of bone mineral density at or near the time of diagnosis of RV can be used to guide prophylaxis or treatment, if osteoporosis is already present. For patients with or at high risk of developing osteoporosis, we suggest weightbearing exercise, calcium and vitamin D supplementation, and bisphosphonates. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/36/17994?source=see_link\">",
"       \"Prevention and treatment of glucocorticoid-induced osteoporosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Smoking cessation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking has been associated with an increased risk for RA [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/40\">",
"     40",
"    </a>",
"    ] and for RV (particularly with the development of nailfold infarcts in men who smoke) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/41\">",
"     41",
"    </a>",
"    ]. Mounting evidence suggests that smoking contributes to the evolution toward RV, making smoking cessation essential in any RA patient with extraarticular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Skin care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with RV are also at significant risk for decubitus (pressure-induced) and lower extremity ulceration. Good skin care may prevent significant infectious complications of RV. Measures used to prevent pressure ulcers in bed-bound patients are discussed in more detail elsewhere, but important components include repositioning of patients regularly (typically every two hours), use of static pressure-reducing mattresses or mattress covers, or, for very high-risk patients, use of dynamic support systems. For ambulatory patients, the incidence of lower extremity skin ulcers may be reduced by avoiding pressure due to poorly fitting shoes, braces, or orthotics. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/1/1049?source=see_link\">",
"     \"Prevention of pressure ulcers\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited data are available concerning the outcome of patients with RV.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      These patients appear to have a worse outcome than those with RA alone (adjusted hazard ratio for death equals 1.26) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Reported survival rates have ranged from 57 percent at five years [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/39\">",
"       39",
"      </a>",
"      ] to almost 80 percent at 10 years [",
"      <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The variability in survival may be related to factors such as different therapies employed and worse outcomes in patients with severe systemic disease or in the rare patient with large-vessel vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common cause of death in 61 patients with RV, in one study, was infection [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/43\">",
"     43",
"    </a>",
"    ]; only one patient died from vasculitis. This hazard of infection when using high-dose glucocorticoids emphasizes the need to carefully determine if the RV is limited to the skin, thereby requiring minimal additional therapy (see",
"    <a class=\"local\" href=\"#H3\">",
"     'Cutaneous vasculitis'",
"    </a>",
"    above) versus the less common but much more threatening involvement of internal organs. In the previously cited study of 32 RV patients, most of whom were treated with cytotoxic drugs and glucocorticoids, more than one-third died within the first three years [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/39\">",
"     39",
"    </a>",
"    ]. At the time of death, 70 percent showed evidence of vasculitis either clinically or on autopsy, although infection was given as the proximal cause of death in the majority.",
"   </p>",
"   <p>",
"    Involvement of medium-sized arteries often portends more serious complications, coupled with a higher likelihood of treatment-related morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/45\">",
"     45",
"    </a>",
"    ]. Rare patients with large-vessel vasculitis are thought to have a much worse prognosis; they may have an increased likelihood of mononeuritis multiplex or cerebral vasculitis, visceral infarction, or coronary arteritis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/19/22841/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Isolated nailfold vasculitis has a low risk for progression to systemic vasculitis and may be treated symptomatically without resorting to immunosuppressive therapy. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Isolated nailfold infarctions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Opportunistic infection should be excluded in RA patients who appear to have developed RV before the initiation of more intensive immunosuppression. Disseminated herpes zoster has been described as a mimic of RV in immunosuppressed RA patients. Other well-known look-alikes include HIV, viral hepatitis, tuberculosis, and endocarditis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20697?source=see_link&amp;anchor=H23#H23\">",
"       \"Clinical manifestations and diagnosis of rheumatoid vasculitis\", section on 'Differential diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Systemic vasculitis has a poor prognosis without immunosuppressive therapy. We administer",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      (375",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      weekly times four doses) plus high-dose glucocorticoids as the first treatment option for severe RV. This treatment is appropriate for patients with severe visceral involvement, including deep cutaneous ulcers, vasculitic neuropathy, scleritis, digital ischemia, and other significant manifestations of RV. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Systemic vasculitis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Glucocorticoids'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H178919555\">",
"       'Rituximab'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who cannot take",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      or for those who appear to be failing the regimen of rituximab and glucocorticoids, we treat with the combination of daily",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      (up to 2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day, assuming normal renal function) and high-dose glucocorticoids. We use",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"       azathioprine",
"      </a>",
"      (approximately 2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      daily) for maintenance therapy after inducing remission with cyclophosphamide. (See",
"      <a class=\"local\" href=\"#H178919562\">",
"       'Cyclophosphamide'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Maintenance therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Given the toxicities of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      and glucocorticoids when used in combination, prophylactic therapy should be provided for Pneumocystis pneumonia (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16008?source=see_link\">",
"       \"General principles of the use of cyclophosphamide in rheumatic and renal disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25098?source=see_link\">",
"       \"General toxicity of cyclophosphamide and chlorambucil in inflammatory diseases\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The strong encouragement of smoking cessation is important because of the well-established synergy of the risk factor with anti-CCP antibodies in contributing to severe RA. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Smoking cessation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/1\">",
"      Myasoedova E, Crowson CS, Turesson C, et al. Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study. J Rheumatol 2011; 38:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/2\">",
"      Hochberg MC, Johnston SS, John AK. The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006. Curr Med Res Opin 2008; 24:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/3\">",
"      Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010; 363:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/4\">",
"      Hellmann M, Jung N, Owczarczyk K, et al. Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis. Rheumatology (Oxford) 2008; 47:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/5\">",
"      Assmann G, Pfreundschuh M, Voswinkel J. Rituximab in patients with rheumatoid arthritis and vasculitis-associated cutaneous ulcers. Clin Exp Rheumatol 2010; 28:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/6\">",
"      Bywaters EG. A Variant of Rheumatoid Arthritis resembling Palindromic Rheumatism. Ann Rheum Dis 1949; 8:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/7\">",
"      Watts RA, Carruthers DM, Scott DG. Isolated nail fold vasculitis in rheumatoid arthritis. Ann Rheum Dis 1995; 54:927.",
"     </a>",
"    </li>",
"    <li>",
"     Price-Forbes AN, Watts RA, Lane SE, et al. Do we need to treat isolated nailfold vasculitis (NFV) in rheumatoid arthritis (RA) more aggressively? Abstract 848, American College of Rheumatology annual scientific meeting, October 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/9\">",
"      Oien RF, H&aring;kansson A, Hansen BU. Leg ulcers in patients with rheumatoid arthritis--a prospective study of aetiology, wound healing and pain reduction after pinch grafting. Rheumatology (Oxford) 2001; 40:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/10\">",
"      Tuveri M, Generini S, Matucci-Cerinic M, Aloe L. NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet 2000; 356:1739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/11\">",
"      Kamali S, Polat NG, Kasapoglu E, et al. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sj&ouml;gren's syndrome, and Wegener's granulomatosis. Clin Rheumatol 2005; 24:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/12\">",
"      Harper L, Cockwell P, Howie AJ, et al. Focal segmental necrotizing glomerulonephritis in rheumatoid arthritis. QJM 1997; 90:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/13\">",
"      Kawakami T, Yamazaki M, Kawasaki K, et al. Therapeutic effect of argatroban on rheumatoid vasculitis with antiphosphatidylserine-prothrombin complex antibody. Arch Dermatol 2008; 144:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/14\">",
"      Scott DG, Bacon PA. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med 1984; 76:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/15\">",
"      Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology 1984; 91:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/16\">",
"      Messmer EM, Foster CS. Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management. Cornea 1995; 14:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/17\">",
"      Breedveld FC. Vasculitis associated with connective tissue disease. Baillieres Clin Rheumatol 1997; 11:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/18\">",
"      Abel T, Andrews BS, Cunningham PH, et al. Rheumatoid vasculitis: effect of cyclophosphamide on the clinical course and levels of circulating immune complexes. Ann Intern Med 1980; 93:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/19\">",
"      Pu&eacute;chal X, Gottenberg JE, Berthelot JM, et al. Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab Registry. Arthritis Care Res (Hoboken) 2012; 64:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/20\">",
"      Keogh KA, Ytterberg SR, Fervenza FC, et al. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 2006; 173:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/21\">",
"      Flossmann O, Jones RB, Jayne DR, Luqmani RA. Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis? Ann Rheum Dis 2006; 65:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/22\">",
"      Heurkens AH, Westedt ML, Breedveld FC. Prednisone plus azathioprine treatment in patients with rheumatoid arthritis complicated by vasculitis. Arch Intern Med 1991; 151:2249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/23\">",
"      Combe B, Didry C, Gutierrez M, et al. Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis. Eur J Med 1993; 2:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/24\">",
"      Nicholls A, Snaith ML, Maini RN, Scott JT. Proceedings: Controlled trial of azathioprine in rheumatoid vasculitis. Ann Rheum Dis 1973; 32:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/25\">",
"      Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005; 352:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/26\">",
"      Hoffman GS, Cinta-Cid M, Rendt KE, et al. Prednisone and Infliximab for Giant Cell Arteritis: A Randomized, Double-blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety. Ann Intern Med 2006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/27\">",
"      Bartolucci P, Ramanoelina J, Cohen P, et al. Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology (Oxford) 2002; 41:1126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/28\">",
"      Unger L, Kayser M, N&uuml;sslein HG. Successful treatment of severe rheumatoid vasculitis by infliximab. Ann Rheum Dis 2003; 62:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/29\">",
"      Garcia-Porrua C, Gonz&aacute;lez-Gay MA. Successful treatment of refractory mononeuritis multiplex secondary to rheumatoid arthritis with the anti-tumour necrosis factor alpha monoclonal antibody infliximab. Rheumatology (Oxford) 2002; 41:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/30\">",
"      van der Bijl AE, Allaart CF, Van Vugt J, et al. Rheumatoid vasculitis treated with infliximab. J Rheumatol 2005; 32:1607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/31\">",
"      Garcia-Porrua C, Gonzalez-Gay MA, Quevedo V. Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis? J Rheumatol 2006; 33:433; author reply 433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/32\">",
"      Cunnane G, Warnock M, Fye KH, Daikh DI. Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum 2002; 47:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/33\">",
"      Galaria NA, Werth VP, Schumacher HR. Leukocytoclastic vasculitis due to etanercept. J Rheumatol 2000; 27:2041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/34\">",
"      Brion PH, Mittal-Henkle A, Kalunian KC. Autoimmune skin rashes associated with etanercept for rheumatoid arthritis. Ann Intern Med 1999; 131:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/35\">",
"      Livermore PA, Murray KJ. Anti-tumour necrosis factor therapy associated with cutaneous vasculitis. Rheumatology (Oxford) 2002; 41:1450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/36\">",
"      McCain ME, Quinet RJ, Davis WE. Etanercept and infliximab associated with cutaneous vasculitis. Rheumatology (Oxford) 2002; 41:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/37\">",
"      Mohan N, Edwards ET, Cupps TR, et al. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol 2004; 31:1955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/38\">",
"      Savolainen HA. Chlorambucil in severe juvenile chronic arthritis: longterm followup with special reference to amyloidosis. J Rheumatol 1999; 26:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/39\">",
"      Pu&eacute;chal X, Said G, Hilliquin P, et al. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 1995; 38:1618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/40\">",
"      Karlson EW, Lee IM, Cook NR, et al. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum 1999; 42:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/41\">",
"      Struthers GR, Scott DL, Delamere JP, et al. Smoking and rheumatoid vasculitis. Rheumatol Int 1981; 1:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/42\">",
"      Albano SA, Santana-Sahagun E, Weisman MH. Cigarette smoking and rheumatoid arthritis. Semin Arthritis Rheum 2001; 31:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/43\">",
"      Voskuyl AE, Zwinderman AH, Westedt ML, et al. The mortality of rheumatoid vasculitis compared with rheumatoid arthritis. Arthritis Rheum 1996; 39:266.",
"     </a>",
"    </li>",
"    <li>",
"     Bacon PA. Vasculitis from the rheumatologist's viewpoint, Gross WL (Ed), Plenum Press, New York 1993. p.185.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/19/22841/abstract/45\">",
"      Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 1981; 60:288.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8228 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-27.109.116.13-0D0D3C1A28-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22841=[""].join("\n");
var outline_f22_19_22841=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      THE CLINICAL CONTEXT OF RV",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CUTANEOUS VASCULITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Isolated nailfold infarctions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Leg ulceration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SYSTEMIC VASCULITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Initial therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H178919555\">",
"      - Rituximab",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H178919562\">",
"      - Cyclophosphamide",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Alternatives to rituximab and cyclophosphamide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H180542524\">",
"      Azathioprine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H180542630\">",
"      Other agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Maintenance therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Relapse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Adjunctive care",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Preventing side effects of therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Skin care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/8228\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/8228|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/17/21776\" title=\"picture 1\">",
"      Nailfold infarction in RV 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/35/44592\" title=\"picture 2\">",
"      Healed cutaneous ulcers",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/26/9641?source=related_link\">",
"      Clinical manifestations and diagnosis of polyarteritis nodosa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20697?source=related_link\">",
"      Clinical manifestations and diagnosis of rheumatoid vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/26/42407?source=related_link\">",
"      Epidemiology and pathogenesis of rheumatoid vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16008?source=related_link\">",
"      General principles of the use of cyclophosphamide in rheumatic and renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25098?source=related_link\">",
"      General toxicity of cyclophosphamide and chlorambucil in inflammatory diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/32/34314?source=related_link\">",
"      Initial immunosuppressive therapy in granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/23/6521?source=related_link\">",
"      Maintenance immunosuppressive therapy in granulomatosis with polyangiitis (Wegener&rsquo;s) and microscopic polyangiitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32410?source=related_link\">",
"      Medical management of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/63/10232?source=related_link\">",
"      Pharmacology and side effects of azathioprine when used in rheumatic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/36/17994?source=related_link\">",
"      Prevention and treatment of glucocorticoid-induced osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/1/1049?source=related_link\">",
"      Prevention of pressure ulcers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28119?source=related_link\">",
"      Treatment and prognosis of polyarteritis nodosa",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_19_22842="Gottron papules";
var content_f22_19_22842=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F63383%7EDERM%2F75246%7EDERM%2F76704&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F63383%7EDERM%2F75246%7EDERM%2F76704&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gottron's papules in dermatomyositis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple violaceous, scaly papules are present overlying the joints on the dorsal hand.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gottron's sign in dermatomyositis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Macular violaceous erythema is present overlying the joints of the hand.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Gottron's sign",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 328px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hyperpigmented patches are present on the dorsal hand.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22842=[""].join("\n");
var outline_f22_19_22842=null;
var title_f22_19_22843="Properties of opioid receptors";
var content_f22_19_22843=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F72705&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F72705&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Properties of opioid receptors",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Mu",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Mu1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Supraspinal analgesia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Bradycardia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Sedation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Mu2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Respiratory depression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Euphoria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Physical dependence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Delta",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Spinal analgesia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Respiratory depression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Kappa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Spinal analgesia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Respiratory depression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sedation",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22843=[""].join("\n");
var outline_f22_19_22843=null;
var title_f22_19_22844="Severity of AR in adults";
var content_f22_19_22844=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F53536&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F53536&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Severity of aortic regurgitation (AR) in adults",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mild",
"       </td>",
"       <td class=\"subtitle1\">",
"        Moderate",
"       </td>",
"       <td class=\"subtitle1\">",
"        Severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"        Structural parameters",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Left ventricular size",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal or dilated",
"       </td>",
"       <td>",
"        Dilated, except acute AR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aortic leaflets",
"       </td>",
"       <td>",
"        Normal or abnormal",
"       </td>",
"       <td>",
"        Normal or abnormal",
"       </td>",
"       <td>",
"        Abnormal/flail, or wide coaptation defect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"        Doppler parameters",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Color Doppler jet width",
"       </td>",
"       <td>",
"        Central jet, width &lt;25 percent of LVOT",
"       </td>",
"       <td>",
"        Central jet, width 25 to 65 percent of LVOT",
"       </td>",
"       <td>",
"        Central jet, width &gt;65 percent of LVOT",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Doppler vena contracta width",
"       </td>",
"       <td>",
"        &lt;3 mm",
"       </td>",
"       <td>",
"        3 to 6 mm",
"       </td>",
"       <td>",
"        &gt;6 mm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"        Quantitative parameters",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Regurgitant volume",
"       </td>",
"       <td>",
"        &lt;30 mL/beat",
"       </td>",
"       <td>",
"        30 to 59 mL/beat",
"       </td>",
"       <td>",
"        &ge;60 mL/beat",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Regurgitant fraction",
"       </td>",
"       <td>",
"        &lt;30 percent",
"       </td>",
"       <td>",
"        30 to 49 percent",
"       </td>",
"       <td>",
"        &ge;50 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Regurgitant orifice area",
"       </td>",
"       <td>",
"        &lt;0.10 cm2",
"       </td>",
"       <td>",
"        0.10 to 0.29 cm2",
"       </td>",
"       <td>",
"        &ge;0.30 cm2",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     LVOT: left ventricular outflow tract.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Zoghbi WA, Enriquez-Sarano M, Foster E, et al. American Society of Echocardiography Report. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16:777; and Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). J Am Coll Cardiol 2006; 48:e1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22844=[""].join("\n");
var outline_f22_19_22844=null;
var title_f22_19_22845="Linkage disequilibrium";
var content_f22_19_22845=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F76528&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F76528&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Linkage disequilibrium",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 433px; height: 198px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In this hypothetical example, the A1 and B1 alleles are more often found on the same chromosome than would be anticipated by chance alone. The same is true for the A2 and B2 alleles. Consequently, there is a deficiency of A1 B2 and A2 B1 haplotypes. This discrepancy between the observed and expected haplotype frequencies is linkage disequilibrium.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22845=[""].join("\n");
var outline_f22_19_22845=null;
var title_f22_19_22846="Risk groups allogeneic HCT";
var content_f22_19_22846=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F88591&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F88591&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Summary of disease, stage, and overall risk groups for allogeneic hematopoietic cell transplantation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"8\" width=\"12%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"8\">",
"        Disease risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        AML-favorable cytogenetics",
"       </td>",
"       <td colspan=\"4\">",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        CLL",
"       </td>",
"       <td colspan=\"4\">",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        CML",
"       </td>",
"       <td colspan=\"4\">",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        Indolent B cell NHL",
"       </td>",
"       <td colspan=\"4\">",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        ALL",
"       </td>",
"       <td colspan=\"4\">",
"        Intermediate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        AML intermediate cytogenetics",
"       </td>",
"       <td colspan=\"4\">",
"        Intermediate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        MDS intermediate cytogenetics",
"       </td>",
"       <td colspan=\"4\">",
"        Intermediate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        Myeloproliferative neoplasms",
"       </td>",
"       <td colspan=\"4\">",
"        Intermediate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        Multiple myeloma",
"       </td>",
"       <td colspan=\"4\">",
"        Intermediate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        Hodgkin lymphoma",
"       </td>",
"       <td colspan=\"4\">",
"        Intermediate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        DLBCL/transformed indolent B-NHL",
"       </td>",
"       <td colspan=\"4\">",
"        Intermediate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        Mantle cell lymphoma",
"       </td>",
"       <td colspan=\"4\">",
"        Intermediate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        T cell lymphoma, nodal",
"       </td>",
"       <td colspan=\"4\">",
"        Intermediate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        AML adverse cytogenetics",
"       </td>",
"       <td colspan=\"4\">",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        MDS adverse cytogenetics",
"       </td>",
"       <td colspan=\"4\">",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        T cell lymphoma, extranodal",
"       </td>",
"       <td colspan=\"4\">",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"8\">",
"        Stage risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        First CR",
"       </td>",
"       <td colspan=\"4\">",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        Second or subsequent CR",
"       </td>",
"       <td colspan=\"4\">",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        First PR",
"       </td>",
"       <td colspan=\"4\">",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        Untreated",
"       </td>",
"       <td colspan=\"4\">",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        Chronic-phase CML",
"       </td>",
"       <td colspan=\"4\">",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        Second or subsequent PR (if RIC)",
"       </td>",
"       <td colspan=\"4\">",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        Second or subsequent PR (if MAC)",
"       </td>",
"       <td colspan=\"4\">",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        Induction failure",
"       </td>",
"       <td colspan=\"4\">",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        Active relapse",
"       </td>",
"       <td colspan=\"4\">",
"        High",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\" colspan=\"4\">",
"        Accelerated or blast-phase CML",
"       </td>",
"       <td colspan=\"4\">",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"8\">",
"        Overall risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Disease risk",
"       </td>",
"       <td class=\"subtitle2\">",
"        Stage risk",
"       </td>",
"       <td class=\"subtitle2\">",
"        Percent of patients",
"       </td>",
"       <td class=\"subtitle2\">",
"        Overall risk",
"       </td>",
"       <td class=\"subtitle2\">",
"        Four year OS (95% CI), p&lt;0.001",
"       </td>",
"       <td class=\"subtitle2\">",
"        Four year PFS (95% CI), p&lt;0.001",
"       </td>",
"       <td class=\"subtitle2\">",
"        Four year CIR (95% CI), p&lt;0.001",
"       </td>",
"       <td class=\"subtitle2\">",
"        Four year NRM (95% CI), p = 0.11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        Low",
"       </td>",
"       <td class=\"centered\">",
"        Low",
"       </td>",
"       <td class=\"centered\">",
"        15",
"       </td>",
"       <td class=\"centered\">",
"        Low",
"       </td>",
"       <td class=\"centered\">",
"        64 percent",
"        <br/>",
"        (56 to 70 percent)",
"       </td>",
"       <td class=\"centered\">",
"        56 percent",
"        <br/>",
"        (48 to 63 percent)",
"       </td>",
"       <td class=\"centered\">",
"        19 percent",
"        <br/>",
"        (13 to 24 percent)",
"       </td>",
"       <td class=\"centered\">",
"        26 percent",
"        <br/>",
"        (19 to 32 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        Low",
"       </td>",
"       <td class=\"centered\">",
"        High",
"       </td>",
"       <td class=\"centered\">",
"        10",
"       </td>",
"       <td class=\"centered\">",
"        Intermediate",
"       </td>",
"       <td class=\"centered\">",
"        46 percent",
"        <br/>",
"        (42 to 50 percent)",
"       </td>",
"       <td class=\"centered\">",
"        40 percent",
"        <br/>",
"        (36 to 43 percent)",
"       </td>",
"       <td class=\"centered\">",
"        36 percent",
"        <br/>",
"        (33 to 40 percent)",
"       </td>",
"       <td class=\"centered\">",
"        24 percent",
"        <br/>",
"        (21 to 27 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        Intermediate",
"       </td>",
"       <td class=\"centered\">",
"        Low",
"       </td>",
"       <td class=\"centered\">",
"        45",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        Intermediate",
"       </td>",
"       <td class=\"centered\">",
"        High",
"       </td>",
"       <td class=\"centered\">",
"        17",
"       </td>",
"       <td class=\"centered\">",
"        High",
"       </td>",
"       <td class=\"centered\">",
"        26 percent",
"        <br/>",
"        (21 to 31 percent)",
"       </td>",
"       <td class=\"centered\">",
"        18 percent",
"        <br/>",
"        (14 to 22 percent)",
"       </td>",
"       <td class=\"centered\">",
"        55 percent",
"        <br/>",
"        (50 to 60 percent)",
"       </td>",
"       <td class=\"centered\">",
"        27 percent",
"        <br/>",
"        (22 to 32 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        High",
"       </td>",
"       <td class=\"centered\">",
"        Low",
"       </td>",
"       <td class=\"centered\">",
"        10",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        High",
"       </td>",
"       <td class=\"centered\">",
"        High",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        Very high",
"       </td>",
"       <td class=\"centered\">",
"        6 percent",
"        <br/>",
"        (0 to 21 percent)",
"       </td>",
"       <td class=\"centered\">",
"        6 percent",
"        <br/>",
"        (0 to 21 percent)",
"       </td>",
"       <td class=\"centered\">",
"        63 percent",
"        <br/>",
"        (44 to 81 percent)",
"       </td>",
"       <td class=\"centered\">",
"        31 percent",
"        <br/>",
"        (18 to 45 percent)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    A disease risk index was created using data from 1539 patients who underwent allogeneic hematopoietic cell transplantation (HCT) at Dana-Farber Cancer Institute/Brigham and Women's Hospital from 2000 to 2009, and was validated in an independent cohort of 672 patients who underwent transplant at the Fred Hutchinson Cancer Research Center. Sixteen defined underlying diseases were categorized as low risk, high risk, or intermediate risk. Disease stage was categorized as low risk or high risk. These two ratings were then combined to define four risk groups with significantly different estimated rates of overall survival (OS), progression-free survival (PFS), cumulative incidence of relapse (CIR), and non-relapse mortality (NRM) at four years.",
"    <div class=\"footnotes\">",
"     AML: acute myeloid leukemia; CLL: chronic lymphocytic leukemia; CML: chronic myelogenous leukemia; NHL: non-Hodgkin lymphoma; ALL: acute lymphoblastic leukemia; MDS: myelodysplastic syndrome; DLBCL: diffuse large B cell lymphoma; CR: complete remission; PR: partial remission; RIC: reduced-intensity conditioning; MAC: myeloablative conditioning; OS: overall survival; %: percent; CI: confidence interval; PFS: progression-free survival; CIR: cumulative incidence of relapse; NRM: cumulative incidence of nonrelapse mortality.",
"    </div>",
"    <div class=\"reference\">",
"     This research was originally published in Blood. Armand P, Gibson CJ, Cutler C, et al. A disease risk index for patients undergoing allogeneic stem cell transplantation. Blood 2012; 120:905. Copyright &copy; 2012 The American Society of Hematology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22846=[""].join("\n");
var outline_f22_19_22846=null;
var title_f22_19_22847="Large volume nebulizer";
var content_f22_19_22847=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F83685&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F83685&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Large volume nebulizer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 264px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A large volume nebulizer, such as the HEART&trade; nebulizer shown here, can generate around 30 mL/hr of aerosol.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Photo courtesy of Westmed, Inc. Reproduced with permission. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_19_22847=[""].join("\n");
var outline_f22_19_22847=null;
